<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>When The Test Lies: Ultimate DTA Course (V4)</title>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:ital,wght@0,400;0,600;0,700;1,400;1,600&amp;family=Source+Sans+Pro:wght@300;400;600;700&amp;display=swap" rel="stylesheet"/>
<style>
    :root {
      --navy: #1E2761;
      --deep-navy: #141B3D;
      --gold: #D4AF37;
      --cream: #FAF8F5;
      --text: #2D3748;
      --light-text: #718096;
      --red: #C53030;
      --green: #22c55e;
      --teal: #00D4AA;
      --purple: #A855F7;
      --orange: #F97316;
      --blood-red: #8B0000;
      --pink: #EC4899;
      --transition: 0.5s cubic-bezier(0.4, 0, 0.2, 1);
    }

    * { margin: 0; padding: 0; box-sizing: border-box; }

    html, body {
      height: 100%;
      font-family: 'Source Sans Pro', sans-serif;
      background: var(--deep-navy);
      color: var(--cream);
    }

    .course-container { display: flex; height: 100vh; overflow: hidden; }

    .sidebar {
      width: 280px;
      background: linear-gradient(180deg, var(--deep-navy) 0%, #0a0f1a 100%);
      border-right: 1px solid rgba(212,175,55,0.2);
      display: flex;
      flex-direction: column;
      flex-shrink: 0;
    }

    /* mobile sidebar handled by hamburger toggle below */

    .sidebar-header { padding: 1.25rem; border-bottom: 1px solid rgba(212,175,55,0.2); }
    .sidebar-header h1 { font-family: 'Cormorant Garamond', serif; font-size: 1.2rem; font-weight: 700; color: var(--gold); }
    .sidebar-header p { font-size: 0.7rem; color: rgba(255,255,255,0.6); }

    .module-list { flex: 1; overflow-y: auto; padding: 0.5rem 0; }

    .module-item {
      display: flex; align-items: center; gap: 0.5rem;
      padding: 0.5rem 0.75rem; cursor: pointer;
      border-left: 3px solid transparent; transition: all 0.2s;
    }
    .module-item:hover { background: rgba(212,175,55,0.1); }
    .module-item.active { background: rgba(212,175,55,0.15); border-left-color: var(--gold); }
    .module-item.completed .module-number { background: var(--green); color: white; }

    .module-number {
      width: 22px; height: 22px; border-radius: 50%;
      background: rgba(255,255,255,0.1);
      display: flex; align-items: center; justify-content: center;
      font-size: 0.65rem; font-weight: 700; flex-shrink: 0;
    }
    .module-item.active .module-number { background: var(--gold); color: var(--navy); }

    .module-info { flex: 1; min-width: 0; }
    .module-title { font-size: 0.75rem; font-weight: 600; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; }
    .module-subtitle { font-size: 0.6rem; color: rgba(255,255,255,0.5); }

    .sidebar-footer {
      padding: 0.6rem 0.75rem; border-top: 1px solid rgba(212,175,55,0.2);
      font-size: 0.6rem; color: rgba(255,255,255,0.4); line-height: 1.4;
    }

    .main-content { flex: 1; display: flex; flex-direction: column; overflow: hidden; }

    .content-header {
      padding: 0.6rem 1.25rem;
      background: rgba(0,0,0,0.3);
      border-bottom: 1px solid rgba(212,175,55,0.2);
      display: flex; align-items: center; justify-content: space-between;
    }
    .breadcrumb { font-size: 0.75rem; color: rgba(255,255,255,0.6); }
    .breadcrumb span { color: var(--gold); }
    .header-actions { display: flex; gap: 0.4rem; }

    .btn {
      padding: 0.35rem 0.7rem; border: 1px solid rgba(212,175,55,0.3);
      border-radius: 6px; background: rgba(255,255,255,0.05);
      color: var(--cream); font-size: 0.7rem; cursor: pointer; transition: all 0.2s;
    }
    .btn:hover { background: rgba(212,175,55,0.2); border-color: var(--gold); }
    .btn.primary { background: var(--gold); color: var(--navy); border-color: var(--gold); font-weight: 600; }

    .content-body { flex: 1; overflow: hidden; display: flex; }
    .slides-container { flex: 1; position: relative; overflow: hidden; }
    .module-slides { display: none; width: 100%; height: 100%; }
    .module-slides.active { display: block; }

    .slide {
      position: absolute; top: 0; left: 0; width: 100%; height: 100%;
      display: flex; flex-direction: column; justify-content: flex-start; align-items: center;
      padding: 1.25rem 1.25rem 3rem 1.25rem; padding-top: 1.5rem;
      opacity: 0; visibility: hidden;
      transition: opacity var(--transition), visibility var(--transition);
      overflow-y: auto; overflow-x: hidden;
    }
    .slide .content { margin-top: auto; margin-bottom: auto; }
    .slide.active { opacity: 1; visibility: visible; }
    .slide.dark { background: var(--deep-navy); }
    .slide.black { background: #000; }
    .slide.gradient { background: linear-gradient(135deg, var(--deep-navy) 0%, #2a1a4a 100%); }
    .slide.blood { background: linear-gradient(135deg, #1a0a0a 0%, #2d1515 100%); }
    .slide.hope { background: linear-gradient(135deg, #0a1a0a 0%, #152d15 100%); }
    .slide.fraud { background: linear-gradient(135deg, #1a1a0a 0%, #2d2515 100%); }
    .slide.tb { background: linear-gradient(135deg, #0a0a1a 0%, #15152d 100%); }
    .slide.des { background: linear-gradient(135deg, #1a0a1a 0%, #2d152d 100%); }

    .title { font-family: 'Cormorant Garamond', serif; font-size: clamp(1.4rem, 3.5vw, 2.4rem); font-weight: 700; margin-bottom: 0.6rem; line-height: 1.2; }
    .title.gold { color: var(--gold); }
    .title.red { color: var(--red); }
    .title.green { color: var(--green); }
    .title.pink { color: var(--pink); }

    .subtitle { font-size: clamp(0.85rem, 1.8vw, 1.1rem); color: rgba(255,255,255,0.7); margin-bottom: 1.25rem; }

    .big-number { font-family: 'Cormorant Garamond', serif; font-size: clamp(2.5rem, 10vw, 6rem); font-weight: 700; line-height: 1; }
    .big-number.red { color: var(--red); }
    .big-number.gold { color: var(--gold); }
    .big-number.green { color: var(--green); }

    .refrain {
      font-family: 'Cormorant Garamond', serif;
      font-size: clamp(1.1rem, 2.5vw, 1.7rem);
      font-style: italic; color: var(--gold);
      text-align: center; max-width: 700px; line-height: 1.4;
    }
    .refrain.warning { color: var(--red); border-left: 4px solid var(--red); padding-left: 1.25rem; text-align: left; }
    .refrain.hope { color: var(--green); }

    .rhetorical {
      font-family: 'Cormorant Garamond', serif;
      font-size: clamp(1rem, 2.2vw, 1.5rem);
      color: rgba(255,255,255,0.9);
      text-align: center; max-width: 600px; line-height: 1.5;
    }
    .rhetorical em { color: var(--gold); font-style: normal; }

    .simple-box {
      background: linear-gradient(135deg, rgba(0,212,170,0.1), rgba(0,0,0,0.2));
      border: 2px solid var(--teal); border-radius: 10px;
      padding: 1rem; max-width: 520px; margin: 0.6rem 0;
    }
    .simple-box .simple-title { color: var(--teal); font-size: 0.65rem; font-weight: 700; letter-spacing: 0.1em; margin-bottom: 0.4rem; }
    .simple-box .simple-text { font-size: 0.9rem; line-height: 1.5; }
    .simple-box .simple-text strong { color: var(--gold); }

    .story-card {
      background: rgba(0,0,0,0.3); border-left: 4px solid var(--gold);
      padding: 1rem 1.25rem; max-width: 600px; margin: 0.6rem 0;
    }
    .story-card .place { font-size: 0.65rem; color: var(--gold); letter-spacing: 0.1em; margin-bottom: 0.35rem; }
    .story-card .narrative { font-family: 'Cormorant Garamond', serif; font-size: 0.95rem; line-height: 1.5; color: rgba(255,255,255,0.9); }
    .story-card .source { font-size: 0.6rem; color: rgba(255,255,255,0.5); margin-top: 0.6rem; font-style: italic; }
    .story-card.pink { border-left-color: var(--pink); }
    .story-card.pink .place { color: var(--pink); }

    /* DECISION TREES */
    .decision-tree {
      background: rgba(0,0,0,0.4); border: 2px solid var(--gold);
      border-radius: 12px; padding: 1rem; max-width: 650px; width: 100%;
    }
    .decision-tree h4 { color: var(--gold); font-family: 'Cormorant Garamond', serif; font-size: 0.9rem; margin-bottom: 0.75rem; text-align: center; }

    .tree-row { display: flex; justify-content: center; gap: 0.4rem; margin: 0.3rem 0; flex-wrap: wrap; }
    .tree-node {
      background: var(--navy); border: 2px solid var(--gold);
      border-radius: 6px; padding: 0.4rem 0.6rem;
      text-align: center; min-width: 70px; font-size: 0.7rem;
    }
    .tree-node.root { background: var(--gold); color: var(--navy); font-weight: 700; }
    .tree-node.question { background: var(--purple); color: white; border-color: var(--purple); }
    .tree-node.positive { background: rgba(197,48,48,0.3); border-color: var(--red); }
    .tree-node.negative { background: rgba(34,197,94,0.3); border-color: var(--green); }
    .tree-node.action { background: var(--teal); color: var(--navy); border-color: var(--teal); }
    .tree-node.warning { background: var(--orange); color: white; border-color: var(--orange); }
    .tree-node.tp { background: var(--green); color: white; border-color: var(--green); }
    .tree-node.fp { background: var(--red); color: white; border-color: var(--red); }
    .tree-node.fn { background: var(--orange); color: white; border-color: var(--orange); }
    .tree-node.tn { background: var(--teal); color: var(--navy); border-color: var(--teal); }
    .tree-node.pink { background: var(--pink); color: white; border-color: var(--pink); }
    .tree-node small { display: block; font-size: 0.55rem; opacity: 0.85; margin-top: 0.15rem; }

    .tree-arrow { color: var(--gold); font-size: 1rem; text-align: center; margin: 0.15rem 0; }
    .tree-branch { display: flex; gap: 1.5rem; justify-content: center; margin-top: 0.25rem; flex-wrap: wrap; }
    .tree-branch-item { display: flex; flex-direction: column; align-items: center; }
    .tree-label { font-size: 0.55rem; color: rgba(255,255,255,0.6); margin: 0.15rem 0; }

    /* SROC Visualization */
    .sroc-container {
      background: rgba(0,0,0,0.5); border: 2px solid var(--purple);
      border-radius: 12px; padding: 1rem; max-width: 400px; width: 100%;
    }
    .sroc-container h4 { color: var(--purple); text-align: center; margin-bottom: 0.75rem; font-family: 'Cormorant Garamond', serif; font-size: 0.9rem; }
    .sroc-plot {
      position: relative; width: 100%; height: 200px;
      background: linear-gradient(135deg, rgba(168,85,247,0.1) 0%, rgba(0,0,0,0.3) 100%);
      border: 1px solid rgba(255,255,255,0.2); border-radius: 8px;
    }
    .sroc-axis-label { position: absolute; font-size: 0.55rem; color: rgba(255,255,255,0.6); }
    .sroc-axis-label.x { bottom: -18px; left: 50%; transform: translateX(-50%); }
    .sroc-axis-label.y { top: 50%; left: -40px; transform: rotate(-90deg) translateX(-50%); transform-origin: center; }
    .sroc-curve { position: absolute; top: 10%; left: 10%; width: 80%; height: 80%; }
    .sroc-curve svg { width: 100%; height: 100%; }
    .sroc-dot { position: absolute; width: 8px; height: 8px; background: var(--gold); border-radius: 50%; transform: translate(-50%, -50%); }
    .sroc-legend { display: flex; gap: 1rem; justify-content: center; margin-top: 0.5rem; font-size: 0.6rem; }
    .sroc-legend-item { display: flex; align-items: center; gap: 0.25rem; }
    .sroc-legend-dot { width: 8px; height: 8px; border-radius: 50%; }

    /* Fagan Nomogram */
    .fagan-container {
      background: rgba(0,0,0,0.4); border: 2px solid var(--purple);
      border-radius: 12px; padding: 1rem; max-width: 550px; width: 100%;
    }
    .fagan-container h4 { color: var(--purple); text-align: center; margin-bottom: 0.75rem; font-family: 'Cormorant Garamond', serif; font-size: 0.9rem; }
    .fagan-visual {
      display: flex; justify-content: space-between; align-items: stretch;
      height: 180px; position: relative; padding: 0 0.75rem;
    }
    .fagan-scale {
      display: flex; flex-direction: column; justify-content: space-between;
      font-size: 0.6rem; color: rgba(255,255,255,0.7); width: 55px; text-align: center;
    }
    .fagan-scale-title { font-size: 0.55rem; color: var(--gold); margin-bottom: 0.2rem; }
    .fagan-line { width: 2px; background: var(--gold); position: relative; }
    .fagan-marker {
      position: absolute; width: 10px; height: 10px; border-radius: 50%;
      background: var(--gold); left: -4px; transform: translateY(-50%);
    }
    .fagan-result { font-size: 0.65rem; text-align: center; margin-top: 0.4rem; color: rgba(255,255,255,0.8); }

    /* Interactive Calculator */
    .calculator {
      background: rgba(0,0,0,0.4); border: 2px solid var(--teal);
      border-radius: 12px; padding: 1rem; max-width: 500px; width: 100%;
    }
    .calculator h4 { color: var(--teal); text-align: center; margin-bottom: 0.75rem; font-family: 'Cormorant Garamond', serif; font-size: 0.9rem; }
    .calc-row { display: flex; align-items: center; gap: 0.75rem; margin: 0.5rem 0; }
    .calc-label { font-size: 0.75rem; min-width: 100px; }
    .calc-slider { flex: 1; -webkit-appearance: none; height: 6px; border-radius: 3px; background: rgba(255,255,255,0.2); }
    .calc-slider::-webkit-slider-thumb { -webkit-appearance: none; width: 16px; height: 16px; border-radius: 50%; background: var(--gold); cursor: pointer; }
    .calc-value { font-size: 0.8rem; font-weight: 700; color: var(--gold); min-width: 50px; text-align: right; }
    .calc-result { background: rgba(34,197,94,0.2); padding: 0.75rem; border-radius: 8px; margin-top: 0.75rem; text-align: center; }
    .calc-result .big { font-size: 1.5rem; font-weight: 700; color: var(--gold); }
    .calc-result .label { font-size: 0.7rem; color: rgba(255,255,255,0.7); }

    /* 2x2 Table */
    .matrix-container { background: rgba(0,0,0,0.3); border-radius: 10px; padding: 0.75rem; max-width: 420px; }
    .matrix-container h4 { color: var(--gold); text-align: center; margin-bottom: 0.6rem; font-family: 'Cormorant Garamond', serif; font-size: 0.85rem; }
    .matrix-table { width: 100%; border-collapse: collapse; font-size: 0.75rem; }
    .matrix-table th, .matrix-table td { border: 1px solid rgba(255,255,255,0.2); padding: 0.5rem; text-align: center; }
    .matrix-table th { background: var(--navy); color: var(--gold); font-size: 0.65rem; }
    .matrix-table .tp { background: rgba(34,197,94,0.3); }
    .matrix-table .fp { background: rgba(197,48,48,0.3); }
    .matrix-table .fn { background: rgba(249,115,22,0.3); }
    .matrix-table .tn { background: rgba(0,212,170,0.3); }

    /* Worked Example */
    .worked-example {
      background: rgba(0,0,0,0.4); border: 2px solid var(--teal);
      border-radius: 10px; padding: 1rem; max-width: 550px; width: 100%;
    }
    .worked-example h4 { color: var(--teal); font-size: 0.85rem; margin-bottom: 0.6rem; }
    .worked-example .step { margin: 0.4rem 0; font-size: 0.8rem; }
    .worked-example .step-num { color: var(--gold); font-weight: 700; }
    .worked-example .calculation { font-family: 'Cormorant Garamond', serif; font-size: 0.95rem; color: var(--gold); margin: 0.25rem 0; }
    .worked-example .result { background: rgba(34,197,94,0.2); padding: 0.4rem; border-radius: 6px; margin-top: 0.4rem; }

    /* QUADAS-2 */
    .quadas-container {
      background: rgba(0,0,0,0.4); border: 2px solid var(--pink);
      border-radius: 12px; padding: 1rem; max-width: 600px; width: 100%;
    }
    .quadas-container h4 { color: var(--pink); text-align: center; margin-bottom: 0.75rem; font-family: 'Cormorant Garamond', serif; font-size: 0.9rem; }
    .quadas-domain {
      display: flex; align-items: flex-start; gap: 0.6rem; margin: 0.5rem 0;
      padding: 0.5rem; background: rgba(255,255,255,0.05); border-radius: 6px;
    }
    .quadas-icon { width: 24px; height: 24px; border-radius: 50%; display: flex; align-items: center; justify-content: center; font-size: 0.7rem; flex-shrink: 0; }
    .quadas-icon.risk { background: var(--red); }
    .quadas-icon.concern { background: var(--orange); }
    .quadas-content h5 { font-size: 0.8rem; color: var(--cream); margin-bottom: 0.15rem; }
    .quadas-content p { font-size: 0.7rem; color: rgba(255,255,255,0.7); }

    .stats-grid { display: flex; gap: 0.6rem; margin: 0.75rem 0; flex-wrap: wrap; justify-content: center; }
    .stat-box { background: var(--navy); padding: 0.6rem 0.8rem; text-align: center; min-width: 90px; border-radius: 8px; }
    .stat-value { font-family: 'Cormorant Garamond', serif; font-size: clamp(1.1rem, 2.2vw, 1.4rem); font-weight: 700; }
    .stat-label { font-size: 0.6rem; opacity: 0.8; margin-top: 0.15rem; }

    .death-toll {
      background: linear-gradient(135deg, rgba(197,48,48,0.3), rgba(0,0,0,0.5));
      border: 2px solid var(--red); padding: 1.25rem; text-align: center;
      max-width: 320px; border-radius: 10px;
    }
    .death-toll .number { font-family: 'Cormorant Garamond', serif; font-size: 2.5rem; font-weight: 700; color: var(--red); }
    .death-toll .label { font-size: 0.8rem; color: rgba(255,255,255,0.8); margin-top: 0.35rem; }

    .lesson-item { display: flex; align-items: flex-start; gap: 0.6rem; margin: 0.4rem 0; max-width: 650px; text-align: left; }
    .lesson-number {
      background: var(--gold); color: var(--navy);
      width: 24px; height: 24px; display: flex; align-items: center; justify-content: center;
      font-weight: 700; flex-shrink: 0; border-radius: 4px; font-size: 0.7rem;
    }
    .lesson-content h4 { font-size: 0.85rem; font-weight: 700; color: var(--cream); margin-bottom: 0.1rem; }
    .lesson-content p { font-size: 0.75rem; color: rgba(255,255,255,0.7); }

    .formula-box {
      background: rgba(0,0,0,0.4); border: 1px solid var(--purple);
      border-radius: 8px; padding: 0.6rem 1rem;
      font-family: 'Cormorant Garamond', serif; font-size: 1rem;
      text-align: center; max-width: 420px; margin: 0.6rem 0;
    }
    .formula-box .formula { color: var(--gold); margin: 0.3rem 0; }
    .formula-box .label { font-size: 0.7rem; color: rgba(255,255,255,0.6); font-family: 'Source Sans Pro', sans-serif; }

    .gold-line { width: 100px; height: 2px; background: var(--gold); margin: 0.75rem auto; }

    .content { display: flex; flex-direction: column; align-items: center; width: 100%; max-width: 850px; }

    .slide.active .animate { animation: fadeUp 0.5s ease-out forwards; }
    .slide.active .animate.delay-1 { animation-delay: 0.1s; }
    .slide.active .animate.delay-2 { animation-delay: 0.2s; }
    .slide.active .animate.delay-3 { animation-delay: 0.3s; }
    .slide.active .animate.delay-4 { animation-delay: 0.4s; }
    @keyframes fadeUp { from { opacity: 0; transform: translateY(12px); } to { opacity: 1; transform: translateY(0); } }
    .animate { opacity: 0; }

    .slide-nav {
      position: absolute; bottom: 0; left: 0; right: 0;
      display: flex; justify-content: space-between; align-items: flex-end;
      padding: 0.6rem 0.75rem 0.75rem 0.75rem; z-index: 100; pointer-events: none;
    }
    .nav-btn {
      background: rgba(0,0,0,0.5); border: 1px solid rgba(255,255,255,0.2);
      color: white; font-size: 1rem; cursor: pointer; opacity: 0.6;
      padding: 0.35rem 0.5rem; border-radius: 6px; pointer-events: auto; transition: all 0.2s;
    }
    .nav-btn:hover { opacity: 1; border-color: var(--gold); }
    .nav-center { display: flex; flex-direction: column; align-items: center; gap: 0.15rem; pointer-events: auto; }
    .slide-counter { color: rgba(255,255,255,0.6); font-size: 0.7rem; }
    .progress { display: flex; gap: 2px; flex-wrap: wrap; justify-content: center; max-width: 160px; }
    .progress-dot { width: 4px; height: 4px; border-radius: 50%; background: rgba(255,255,255,0.25); cursor: pointer; }
    .progress-dot.active { background: var(--gold); transform: scale(1.2); }

    .quiz-container { background: rgba(255,255,255,0.05); border: 1px solid rgba(212,175,55,0.3); padding: 1rem; max-width: 600px; width: 100%; border-radius: 8px; }
    .quiz-question { font-family: 'Cormorant Garamond', serif; font-size: 1rem; margin-bottom: 0.6rem; color: var(--gold); line-height: 1.4; }
    .quiz-options { display: flex; flex-direction: column; gap: 0.35rem; }
    .quiz-option { background: rgba(255,255,255,0.05); border: 1px solid rgba(255,255,255,0.2); padding: 0.5rem 0.75rem; cursor: pointer; border-radius: 6px; font-size: 0.8rem; text-align: left; min-height: 44px; }
    .quiz-option:hover { background: rgba(212,175,55,0.1); border-color: var(--gold); }
    .quiz-option.correct { background: rgba(34,197,94,0.2); border-color: var(--green); }
    .quiz-option.incorrect { background: rgba(197,48,48,0.2); border-color: var(--red); }
    .quiz-feedback { margin-top: 0.6rem; padding: 0.6rem; border-radius: 6px; display: none; font-size: 0.8rem; }
    .quiz-feedback.show { display: block; }
    .quiz-feedback.correct { background: rgba(34,197,94,0.2); border: 1px solid var(--green); }
    .quiz-feedback.incorrect { background: rgba(197,48,48,0.2); border: 1px solid var(--red); }

    .references { background: rgba(0,0,0,0.3); border: 1px solid rgba(212,175,55,0.3); border-radius: 8px; padding: 1rem; max-width: 600px; text-align: left; font-size: 0.65rem; line-height: 1.6; }
    .references h4 { color: var(--gold); font-size: 0.8rem; margin-bottom: 0.6rem; }
    .references ol { padding-left: 1rem; }
    .references li { margin-bottom: 0.3rem; color: rgba(255,255,255,0.8); }

    /* Patient Decision Aid */
    .decision-aid {
      background: linear-gradient(135deg, rgba(212,175,55,0.1), rgba(0,0,0,0.3));
      border: 2px solid var(--gold); border-radius: 12px; padding: 1rem; max-width: 600px; width: 100%;
    }
    .decision-aid h4 { color: var(--gold); text-align: center; margin-bottom: 0.75rem; font-family: 'Cormorant Garamond', serif; font-size: 0.9rem; }
    .decision-aid-row { display: flex; justify-content: space-between; margin: 0.5rem 0; padding: 0.5rem; background: rgba(0,0,0,0.2); border-radius: 6px; }
    .decision-aid-label { font-size: 0.75rem; }
    .decision-aid-value { font-size: 0.75rem; font-weight: 700; }
    .decision-aid-value.benefit { color: var(--green); }
    .decision-aid-value.harm { color: var(--red); }
    .decision-aid-question { text-align: center; margin-top: 0.75rem; font-style: italic; color: var(--gold); font-size: 0.85rem; }

    .text-center { text-align: center; }
    .mobile-menu-toggle{display:none;position:fixed;top:12px;left:12px;z-index:1001;background:#1E2761;border:1px solid #D4AF37;color:#D4AF37;width:40px;height:40px;border-radius:8px;font-size:1.2rem;cursor:pointer;align-items:center;justify-content:center;}
    @media(max-width:768px){.mobile-menu-toggle{display:flex;}.sidebar{transform:translateX(-100%);transition:transform 0.3s ease;position:fixed;z-index:1000;height:100vh;}.sidebar.open{transform:translateX(0);}.sidebar-overlay{display:none;position:fixed;inset:0;background:rgba(0,0,0,0.5);z-index:999;}.sidebar-overlay.show{display:block;}}
    .skip-link{position:absolute;top:-40px;left:0;background:#D4AF37;color:#1E2761;padding:8px 16px;z-index:100;transition:top 0.3s;font-family:'Source Sans Pro',sans-serif;text-decoration:none;font-weight:600;}.skip-link:focus{top:0;}

    /* Focus-visible styles for keyboard navigation */
    :focus-visible {
      outline: 2px solid var(--gold, #D4AF37);
      outline-offset: 2px;
    }

    :focus:not(:focus-visible) {
      outline: none;
    }

    button:focus-visible,
    a:focus-visible,
    [role="button"]:focus-visible,
    input:focus-visible,
    select:focus-visible,
    textarea:focus-visible {
      outline: 2px solid var(--gold, #D4AF37);
      outline-offset: 2px;
      box-shadow: 0 0 0 4px rgba(212, 175, 55, 0.3);
    }

    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
        scroll-behavior: auto !important;
      }
    }

    /* ==================== STORY-BOX PATTERN ==================== */
    .story-box {
      background: linear-gradient(135deg, rgba(0,0,0,0.5), rgba(30,39,97,0.3));
      border: 2px solid var(--gold);
      border-radius: 14px;
      padding: 1.25rem;
      max-width: 680px;
      width: 100%;
    }
    .story-opener {
      font-family: 'Cormorant Garamond', serif;
      font-size: clamp(1rem, 2vw, 1.3rem);
      font-style: italic;
      color: var(--gold);
      text-align: center;
      margin-bottom: 1rem;
      line-height: 1.4;
    }
    .real-data-box {
      background: rgba(0,0,0,0.4);
      border-left: 4px solid var(--teal);
      border-radius: 0 8px 8px 0;
      padding: 0.75rem 1rem;
      margin-bottom: 1rem;
    }
    .real-data-box h4 {
      color: var(--teal);
      font-size: 0.6rem;
      letter-spacing: 0.15em;
      font-weight: 700;
      margin-bottom: 0.4rem;
    }
    .real-data-box p {
      font-size: 0.8rem;
      line-height: 1.5;
      color: rgba(255,255,255,0.9);
    }
    .data-highlight {
      color: var(--gold);
      font-weight: 700;
    }
    .decision-tree-header {
      font-family: 'Cormorant Garamond', serif;
      font-size: 0.95rem;
      font-weight: 700;
      color: var(--gold);
      text-align: center;
      margin-bottom: 0.5rem;
    }
    .decision-scenario {
      font-size: 0.8rem;
      color: rgba(255,255,255,0.8);
      text-align: center;
      margin-bottom: 0.75rem;
      line-height: 1.4;
    }
    .decision-paths {
      display: flex;
      gap: 0.75rem;
      justify-content: center;
      flex-wrap: wrap;
    }
    .decision-path {
      flex: 1;
      min-width: 200px;
      max-width: 290px;
      background: rgba(0,0,0,0.3);
      border-radius: 10px;
      padding: 0.75rem;
      text-align: center;
      cursor: pointer;
      transition: transform 0.2s, border-color 0.2s;
      border: 2px solid transparent;
    }
    .decision-path:hover, .decision-path:focus {
      transform: translateY(-2px);
    }
    .decision-path.path-a {
      border-color: var(--red);
    }
    .decision-path.path-a:hover, .decision-path.path-a:focus {
      border-color: var(--red);
      box-shadow: 0 0 12px rgba(197,48,48,0.3);
    }
    .decision-path.path-b {
      border-color: var(--green);
    }
    .decision-path.path-b:hover, .decision-path.path-b:focus {
      border-color: var(--green);
      box-shadow: 0 0 12px rgba(34,197,94,0.3);
    }
    .path-label {
      font-size: 0.65rem;
      font-weight: 700;
      letter-spacing: 0.1em;
      margin-bottom: 0.4rem;
    }
    .path-a .path-label { color: var(--red); }
    .path-b .path-label { color: var(--green); }
    .path-choice {
      font-size: 0.78rem;
      color: rgba(255,255,255,0.9);
      margin-bottom: 0.3rem;
    }
    .path-arrow {
      font-size: 1.1rem;
      color: var(--gold);
      margin: 0.15rem 0;
    }
    .path-consequence {
      font-size: 0.75rem;
      color: rgba(255,255,255,0.7);
      margin-bottom: 0.3rem;
      line-height: 1.4;
    }
    .path-outcome {
      font-size: 0.7rem;
      font-weight: 700;
      padding: 0.3rem 0.5rem;
      border-radius: 4px;
      display: inline-block;
    }
    .path-a .path-outcome { background: rgba(197,48,48,0.3); color: var(--red); }
    .path-b .path-outcome { background: rgba(34,197,94,0.3); color: var(--green); }
    .story-revelation {
      margin-top: 1rem;
      background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(0,0,0,0.2));
      border: 1px solid rgba(212,175,55,0.4);
      border-radius: 8px;
      padding: 0.75rem 1rem;
      text-align: center;
    }
    .revelation-label {
      font-size: 0.6rem;
      font-weight: 700;
      letter-spacing: 0.15em;
      color: var(--gold);
      margin-bottom: 0.3rem;
    }
    .revelation-text {
      font-family: 'Cormorant Garamond', serif;
      font-size: 0.9rem;
      color: rgba(255,255,255,0.9);
      line-height: 1.5;
    }
  </style>
</head>
<body>
<a class="skip-link" href="#main-content">Skip to main content</a>
<button aria-expanded="false" aria-label="Toggle navigation menu" class="mobile-menu-toggle" onclick="toggleSidebar()">☰</button>
<div class="sidebar-overlay" onclick="document.querySelector('.sidebar').classList.remove('open');this.classList.remove('show');"></div>
<div class="course-container">
<nav aria-label="Navigazione del corso" class="sidebar" role="navigation">
<div class="sidebar-header">
<a href="index.html" onmouseout="this.style.color='rgba(212,175,55,0.7)'" onmouseover="this.style.color='#D4AF37'" style="display:block;font-size:0.7rem;color:rgba(212,175,55,0.7);text-decoration:none;margin-bottom:0.5rem;">← Course Library</a>
<h1>Quando il test mente</h1>
<p>Ultimate DTA Course (V4)</p>
</div>
<div class="module-list" id="moduleList"></div>
<div class="sidebar-footer">
        "Every positive has a price.<br/>Every negative has a cost."
      </div>
</nav>
<main class="main-content" id="main-content">
<header class="content-header">
<div class="breadcrumb">DTA &gt; <span id="currentModule">The Fraud</span></div>
<div class="header-actions">
<button class="btn" onclick="goToModule(20)">References</button>
<button class="btn primary" onclick="nextSlide()">Continue</button>
</div>
</header>
<div class="content-body">
<div class="slides-container">
 ==================== MODULO 1: LA FRODE (Theranos) ==================== 
<div class="module-slides active" data-module="1">
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai sentito la storia della donna<br/>
                  who promised to <em>cambiare il mondo con una goccia di sangue</em>,<br/>
                  who raised billions on a test that <em>never worked</em>?
                </div>
</div>
</div>
<div class="slide fraud">
<div class="content text-center">
<div class="title gold animate">Palo Alto, 2003</div>
<div class="story-card animate delay-1">
<div class="place">STANFORD UNIVERSITY</div>
<div class="narrative">
                    Un diciannovenne si è ritirato con una visione: centinaia di sangue test da una singola goccia.
                    <br/><br/>
                    Investors believed. Walgreens believed. The Pentagon believed.
                    <br/><br/>
<strong>They gave her $9 billion.</strong>
<br/><br/>
                    Ma i test hanno dato risultati errati. Ai pazienti veniva detto che avevano l'HIV quando non era così. Ai pazienti è stato detto che il loro sangue era normale quando erano <strong>dying</strong>.
                  </div>
<div class="source">Carreyrou J. Bad Blood. 2018</div>
</div>
</div>
</div>
<div class="slide blood">
<div class="content text-center">
<div class="title red animate">L'albero decisionale dell'inganno</div>
<div class="decision-tree animate delay-1">
<h4>What Theranos Did vs. What Should Happen</h4>
<div class="tree-row">
<div class="tree-node root">New Diagnostic Test</div>
</div>
<div class="tree-arrow">↓</div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-label">SHOULD DO</div>
<div class="tree-node action">Validate Against Gold Standard</div>
<div class="tree-arrow">↓</div>
<div class="tree-node action">Publish TP/FP/FN/TN</div>
<div class="tree-arrow">↓</div>
<div class="tree-node tp">FDA Approval</div>
</div>
<div class="tree-branch-item">
<div class="tree-label">THERANOS DID</div>
<div class="tree-node warning">Skip Validation</div>
<div class="tree-arrow">↓</div>
<div class="tree-node warning">Hide Failures</div>
<div class="tree-arrow">↓</div>
<div class="tree-node fp">Harm Patients</div>
</div>
</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "E il test mentì,<br/>
                  e la menzogna era vestita di certezza,<br/>
                  e nessuno ha chiesto la tavola 2×2."
                </div>
<div class="gold-line animate delay-2"></div>
<p class="animate delay-3" style="color:rgba(255,255,255,0.6);font-style:italic;font-size:0.85rem;">
                  Ecco perché studiamo l'accuratezza dei test diagnostici.
                </p>
</div>
</div>
</div>
 ==================== MODULO 2: I QUATTRO RISULTATI ==================== 
<div class="module-slides" data-module="2">
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  When a test speaks,<br/>
                  ci sono solo <em>four possible truths</em>.
                  <br/><br/>
                  Due sono benedizioni. Due sono maledizioni.
                </div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="story-box animate">
<p class="story-opener">Cosa succede quando una revisione sistematica si fida equamente di ogni studio?</p>
<div class="real-data-box">
<h4>REAL DATA</h4>
<p>Le analisi di sensibilità nelle revisioni sistematiche DTA dimostrano costantemente che l'esclusione di studi ad alto rischio di bias modifica le stime aggregate. Nello screening mammografico, i disegni caso-controllo con interpretazione in cieco tendono a gonfiare la sensibilità. Il principio generale è ben documentato: la valutazione della qualità QUADAS-2 può modificare la sensibilità raggruppata <span class="data-highlight">10-15 percentage points</span> quando gli studi distorti vengono rimossi.</p>
</div>
<div class="decision-tree">
<div class="decision-tree-header">L'audit mammografico QUADAS-2</div>
<div class="decision-scenario">Un team di revisione raggruppa 15 studi DTA mammografici. Cinque presentano un alto rischio di bias a causa del disegno caso-controllo e dell'interpretazione non cieca.</div>
<div class="decision-paths">
<div class="decision-path path-a" role="button" tabindex="0">
<div class="path-label">PERCORSO A: raggruppare tutti gli studi</div>
<div class="path-choice">Include all 15 studies regardless of quality</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Biased 2x2 tables inflate TP counts, producing a pooled sensitivity of 87%</div>
<div class="path-outcome">OUTCOME: Overconfidence in screening accuracy</div>
</div>
<div class="decision-path path-b" role="button" tabindex="0">
<div class="path-label">PATH B: Apply Quality Assessment</div>
<div class="path-choice">Exclude high risk-of-bias studies using QUADAS-2</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Remaining 10 low-RoB studies yield sensitivity of approximately 75%</div>
<div class="path-outcome">OUTCOME: Honest numbers guide honest decisions</div>
</div>
</div>
</div>
<div class="story-revelation">
<div class="revelation-label">THE REVELATION</div>
<div class="revelation-text">I quattro risultati (TP, FP, FN, TN) sono affidabili solo se lo studio che li ha prodotti è affidabile. Uno studio parziale contamina l'intera tabella 2x2.</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">L'albero dei risultati</div>
<div class="decision-tree animate delay-1">
<h4>Every Test Result Has a Reality Behind It</h4>
<div class="tree-row"><div class="tree-node root">Patient Tested</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node question">Qual è la VERITÀ?</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-label">Has Disease</div>
<div class="tree-node positive">D+</div>
<div class="tree-arrow">↓</div>
<div class="tree-row" style="gap:0.4rem;">
<div class="tree-node tp">TP<small>Test +</small></div>
<div class="tree-node fn">FN<small>Test -</small></div>
</div>
</div>
<div class="tree-branch-item">
<div class="tree-label">No Disease</div>
<div class="tree-node negative">D-</div>
<div class="tree-arrow">↓</div>
<div class="tree-row" style="gap:0.4rem;">
<div class="tree-node fp">FP<small>Test +</small></div>
<div class="tree-node tn">TN<small>Test -</small></div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La Sacra Tavola 2×2</div>
<div class="matrix-container animate delay-1">
<h4>HIV Rapid Test Example (Real Data)</h4>
<table class="matrix-table">
<tr><th></th><th>HIV+</th><th>HIV-</th><th>Total</th></tr>
<tr><th>Test +</th><td class="tp"><strong>98</strong></td><td class="fp"><strong>3</strong></td><td>101</td></tr>
<tr><th>Test -</th><td class="fn"><strong>2</strong></td><td class="tn"><strong>895</strong></td><td>897</td></tr>
<tr><th>Total</th><td>100</td><td>898</td><td>998</td></tr>
</table>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">DA QUESTA TABELLA NASCE TUTTA LA VERITÀ</div>
<div class="simple-text">
<strong>Sensitivity</strong> = 98/100 = 98%<br/>
<strong>Specificity</strong> = 895/898 = 99.7%
                  </div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "Two outcomes save. Two outcomes harm.<br/>
                  TP, TN: il test ha parlato vero.<br/>
                  FP, FN: il test ha mentito.<br/>
                  Know them by name, for they determine fate."
                </div>
</div>
</div>
</div>
 ==================== MODULO 3: PERIODO FINESTRA HIV ==================== 
<div class="module-slides" data-module="3">
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai sentito parlare del sangue che fu analizzato,<br/>
                  found <em>clean</em>,<br/>
                  e donato a migliaia di persone—<br/>
                  while <em>death swam within it</em>?
                </div>
</div>
</div>
<div class="slide blood">
<div class="content text-center">
<div class="title red animate">La crisi dell'approvvigionamento di sangue, 1985</div>
<div class="story-card animate delay-1">
<div class="place">UNITED STATES</div>
<div class="narrative">
                    When HIV testing began, doctors celebrated: they could now screen the blood supply.
                    <br/><br/>
                    Ma il test aveva a <strong>window period</strong>—settimane dopo l'infezione quando il virus era presente ma <strong>undetectable</strong>.
                    <br/><br/>
                    Il sangue è stato testato. Il sangue è stato "negativo". Il sangue è stato trasfuso.
                    <br/><br/>
<strong>8,000-12,000 Americans</strong> sono stati infettati tramite trasfusioni prima che test migliori chiudessero la finestra.
                  </div>
<div class="source">CDC. MMWR. 1987;36(49):833-840</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">The Window Period Decision Tree</div>
<div class="decision-tree animate delay-1">
<h4>Why False Negatives Are Deadly</h4>
<div class="tree-row"><div class="tree-node root">Person Recently Infected</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node question">Time Since Infection?</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-label">&lt; 2 weeks</div>
<div class="tree-node fn">Test NEGATIVE<small>Virus present!</small></div>
<div class="tree-arrow">↓</div>
<div class="tree-node fp" style="background:var(--blood-red);">Blood Donated<small>Others infected</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">&gt; 4 weeks</div>
<div class="tree-node tp">Test POSITIVE<small>Correctly detected</small></div>
<div class="tree-arrow">↓</div>
<div class="tree-node action">Blood Discarded<small>Supply safe</small></div>
</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La sensibilità cambia Ora</div>
<div class="stats-grid animate delay-1">
<div class="stat-box">
<div class="stat-value" style="color:var(--red);">0%</div>
<div class="stat-label">Day 1-7<br/>Eclipse period</div>
</div>
<div class="stat-box">
<div class="stat-value" style="color:var(--orange);">~50%</div>
<div class="stat-label">Day 14<br/>Seroconversion</div>
</div>
<div class="stat-box">
<div class="stat-value" style="color:var(--gold);">~95%</div>
<div class="stat-label">Day 21<br/>Most detected</div>
</div>
<div class="stat-box">
<div class="stat-value" style="color:var(--green);">99.9%</div>
<div class="stat-label">Day 45+<br/>Window closed</div>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">THE LESSON</div>
<div class="simple-text">
<strong>La sensibilità non è fissa.</strong> It depends on <em>when</em> you test.
                    A "99% sensitive" test may be 0% sensitive in early infection.
                  </div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "E il test ha detto 'pulito'<br/>
                  perché il virus non si era ancora mostrato il suo volto.<br/>
                  E il sangue è stato condiviso,<br/>
                  e l'infezione diffondersi agli innocenti."
                </div>
</div>
</div>
</div>
 ==================== MODULO 4: DES TRAGEDY ==================== 
<div class="module-slides" data-module="4">
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai sentito parlare della pillola somministrata alle madri<br/>
                  to <em>protect their pregnancies</em>,<br/>
                  that planted <em>cancer in their daughters</em><br/>
                  twenty years before it bloomed?
                </div>
</div>
</div>
<div class="slide des">
<div class="content text-center">
<div class="title pink animate">La tragedia del DES, 1938-1971</div>
<div class="story-card pink animate delay-1">
<div class="place">UNITED STATES &amp; EUROPE</div>
<div class="narrative">
                    Diethylstilbestrol (DES) was given to millions of pregnant women to prevent miscarriage.
                    <br/><br/>
                    No proper clinical trial was ever conducted. Doctors <strong>assumed</strong> it worked
                    because it seemed reasonable.
                    <br/><br/>
                    Decades later, their daughters developed a rare cancer: <strong>clear cell adenocarcinoma
                    of the vagina</strong>. A cancer so rare it was a diagnostic signal in itself.
                    <br/><br/>
<strong>5-10 million women</strong> sono stati esposti al danno attraversato generazioni.
                  </div>
<div class="source">Herbst AL et al. N Engl J Med. 1971;284:878-881</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">L'albero decisionale di convalida</div>
<div class="decision-tree animate delay-1">
<h4>What Should Have Happened</h4>
<div class="tree-row"><div class="tree-node root">New Medical Intervention</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node question">È stato testato adeguatamente?</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-label">YES</div>
<div class="tree-node action">Randomized Trial</div>
<div class="tree-arrow">↓</div>
<div class="tree-node action">Long-term Follow-up</div>
<div class="tree-arrow">↓</div>
<div class="tree-node tp">Know True Effects<small>Vantaggi e danni</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">NO (DES)</div>
<div class="tree-node warning">Assumption Only</div>
<div class="tree-arrow">↓</div>
<div class="tree-node warning">Widespread Use</div>
<div class="tree-arrow">↓</div>
<div class="tree-node fp">Hidden Harm<small>Discovered too late</small></div>
</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Il segnale diagnostico</div>
<div class="simple-box animate delay-1">
<div class="simple-title">QUANDO LA RARITÀ DIVENTA PROVE</div>
<div class="simple-text">
                    L'adenocarcinoma a cellule chiare della vagina era così raro nelle giovani donne che
                    <strong>7 cases in one hospital</strong> triggered an investigation.
                    <br/><br/>
                    Il cluster stesso era il test diagnostico:
                    <br/><strong>Sensitivity to DES exposure: nearly 100%</strong>
<br/>Se hai questo cancro a questa età, sei quasi certamente esposto.
                  </div>
</div>
<div class="stats-grid animate delay-2">
<div class="stat-box" style="background:var(--pink);">
<div class="stat-value" style="color:white;">1:1000</div>
<div class="stat-label">Risk of clear cell<br/>cancer in DES daughters</div>
</div>
<div class="stat-box" style="background:var(--red);">
<div class="stat-value" style="color:white;">5-10M</div>
<div class="stat-label">Women exposed<br/>worldwide</div>
</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "E le madri prendevano la pillola nella speranza,<br/>
                  e le figlie crebbero nell'ombra,<br/>
                  e vent'anni dopo sbocciò il cancro—<br/>
                  a diagnosis that indicted a generation of medicine."
                </div>
</div>
</div>
</div>
 ==================== MODULO 5: SENSIBILITÀ E SPECIFICITÀ ==================== 
<div class="module-slides" data-module="5">
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  A test has two virtues and two vices.
                  <br/><br/>
<em>Sensitivity</em>: Può trovare i malati?
                  <br/><br/>
<em>Specificity</em>: Può risparmiare i sani?
                </div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="story-box animate">
<p class="story-opener">Puoi fidarti di un numero di sensibilità di un laboratorio quando il test viene utilizzato nel mondo reale?</p>
<div class="real-data-box">
<h4>REAL DATA</h4>
<p>The BinaxNOW COVID-19 rapid antigen test reported sensitivity of approximately <span class="data-highlight">84-97%</span> in symptomatic individuals in manufacturer studies. However, real-world evaluations found sensitivity as low as <span class="data-highlight">35-64%</span> in individui asintomatici, a seconda della carica virale e dei tempi. La revisione Cochrane dei test antigenici rapidi (Dinnes 2022) ha confermato la sensibilità media di <span class="data-highlight">73%</span> nelle popolazioni sintomatiche e solo <span class="data-highlight">55%</span> nelle popolazioni asintomatiche in oltre 100 valutazioni di studio.</p>
</div>
<div class="decision-tree">
<div class="decision-tree-header">The COVID Rapid Test Paradox: 2020-2021</div>
<div class="decision-scenario">A university plans to screen asymptomatic students weekly before allowing campus access. They read the manufacturer's claim of high sensitivity.</div>
<div class="decision-paths">
<div class="decision-path path-a" role="button" tabindex="0">
<div class="path-label">PATH A: Trust Lab Sensitivity</div>
<div class="path-choice">Rely on manufacturer's high sensitivity figure</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">I portatori asintomatici con basse cariche virali risultano negativi e frequentano le lezioni, diffondendo il virus</div>
<div class="path-outcome">OUTCOME: False sense of safety; campus outbreaks</div>
</div>
<div class="decision-path path-b" role="button" tabindex="0">
<div class="path-label">PERCORSO B: richiesta di dati dal mondo reale</div>
<div class="path-choice">Cercare studi nella popolazione target effettiva (studenti asintomatici)</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Discover sensitivity is roughly 55% in asymptomatic people; add serial testing and other safeguards</div>
<div class="path-outcome">OUTCOME: Layered safety catches more cases</div>
</div>
</div>
</div>
<div class="story-revelation">
<div class="revelation-label">THE REVELATION</div>
<div class="revelation-text">La sensibilità non è una proprietà fissa di un test. Cambia con la popolazione, lo stadio della malattia e il contesto. Chiedi sempre: sensibilità in <em>whom</em>?</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Sensibilità: Il cacciatore</div>
<div class="formula-box animate delay-1">
<div class="label">THE FORMULA</div>
<div class="formula">Sensitivity = TP / (TP + FN)</div>
<div class="label">"Of all the sick, how many did we catch?"</div>
</div>
<div class="worked-example animate delay-2">
<h4>Worked Example: COVID PCR Test</h4>
<div class="step"><span class="step-num">Given:</span> 200 infected patients tested</div>
<div class="step">TP = 196 (correctly positive), FN = 4 (missed)</div>
<div class="calculation">Sensitivity = 196 / (196 + 4) = 196/200 = <strong>98%</strong></div>
<div class="result">Interpretation: Test catches 98 of every 100 infected people</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Specificità: Il guardiano</div>
<div class="formula-box animate delay-1">
<div class="label">THE FORMULA</div>
<div class="formula">Specificity = TN / (TN + FP)</div>
<div class="label">"Of all the healthy, how many did we spare?"</div>
</div>
<div class="worked-example animate delay-2">
<h4>Worked Example: Same COVID PCR Test</h4>
<div class="step"><span class="step-num">Given:</span> 1000 uninfected people tested</div>
<div class="step">TN = 999 (correctly negative), FP = 1 (false alarm)</div>
<div class="calculation">Specificity = 999 / (999 + 1) = 999/1000 = <strong>99.9%</strong></div>
<div class="result">Interpretation: Test correctly clears 999 of every 1000 healthy people</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Le regole della memoria</div>
<div class="decision-tree animate delay-1">
<h4>When to Use Which Test</h4>
<div class="tree-row"><div class="tree-node question">Di cosa hai bisogno?</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-label">RULE OUT disease</div>
<div class="tree-node action">Use HIGH SENSITIVITY</div>
<div class="tree-arrow">↓</div>
<div class="tree-node tp" style="font-size:0.6rem;">SnNout<small>Sensitive Negative = OUT</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">RULE IN disease</div>
<div class="tree-node action">Use HIGH SPECIFICITY</div>
<div class="tree-arrow">↓</div>
<div class="tree-node tp" style="font-size:0.6rem;">SpPin<small>Specific Positive = IN</small></div>
</div>
</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain animate">
                  "La sensibilità cattura i malati.<br/>
                  La specificità risparmia i buoni.<br/>
                  But no test masters both perfectly—<br/>
                  questo è il fardello che dobbiamo affrontare sopportare."
                </div>
</div>
</div>
</div>
 ==================== MODULO 6: L'ERRORE DEL TASSO DI BASE ==================== 
<div class="module-slides" data-module="6">
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai visto il medico<br/>
                  who saw <em>99% accurate</em><br/>
                  and believed a positive result meant <em>99% certainty</em>?
                  <br/><br/>
<em>Questa è la cosa più mortale errore in medicina.</em>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">L'errore del tasso di base</div>
<div class="story-card animate delay-1">
<div class="place">THE PUZZLE</div>
<div class="narrative">
                    A disease affects 1 in 1000 people.<br/>
                    Un test è sensibile al 99% e specifico al 99%.<br/>
                    A patient tests positive.
                    <br/><br/>
<strong>Qual è la probabilità che abbiano la malattia?</strong>
<br/><br/>
                    Most doctors say ~99%. <em>La vera risposta riguarda 9%.</em>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La matematica rivelata</div>
<div class="worked-example animate delay-1">
<h4>Testing 100,000 People (Prevalence 1/1000)</h4>
<div class="step"><span class="step-num">Step 1:</span> 100 have disease, 99,900 healthy</div>
<div class="step"><span class="step-num">Step 2:</span> Of 100 sick: 99 test positive (TP), 1 negative (FN)</div>
<div class="step"><span class="step-num">Step 3:</span> Of 99,900 healthy: 999 test positive (FP), 98,901 negative (TN)</div>
<div class="step"><span class="step-num">Step 4:</span> Total positives = 99 + 999 = <strong>1,098</strong></div>
<div class="calculation">PPV = TP / All Positives = 99 / 1,098 = <strong>9%</strong></div>
<div class="result">Il 91% dei risultati positivi sono FALSI POSITIVI!</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Interactive Base Rate Calculator</div>
<div class="calculator animate delay-1">
<h4>See How Prevalence Changes PPV</h4>
<div class="calc-row">
<div class="calc-label">Prevalence:</div>
<input class="calc-slider" id="prevSlider" max="50" min="0.1" oninput="updateCalc()" step="0.1" type="range" value="1"/>
<div class="calc-value" id="prevValue">1%</div>
</div>
<div class="calc-row">
<div class="calc-label">Sensitivity:</div>
<input class="calc-slider" id="sensSlider" max="100" min="50" oninput="updateCalc()" step="1" type="range" value="99"/>
<div class="calc-value" id="sensValue">99%</div>
</div>
<div class="calc-row">
<div class="calc-label">Specificity:</div>
<input class="calc-slider" id="specSlider" max="100" min="50" oninput="updateCalc()" step="1" type="range" value="99"/>
<div class="calc-value" id="specValue">99%</div>
</div>
<div class="calc-result">
<div class="big" id="ppvResult">9%</div>
<div class="label">Positive Predictive Value (PPV)</div>
<div id="fpRate" style="font-size:0.7rem;color:rgba(255,255,255,0.6);margin-top:0.3rem;">Il 91% dei positivi è falso allarmi</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">L'albero decisionale della prevalenza</div>
<div class="decision-tree animate delay-1">
<h4>Same Test, Different Settings</h4>
<div class="tree-row"><div class="tree-node root">Test: 99% Sens, 99% Spec</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node question">Where Is Testing Done?</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-label">General Pop<br/>0.1%</div>
<div class="tree-node warning">PPV = 9%<small>91% false +</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">High-Risk<br/>10%</div>
<div class="tree-node action">PPV = 92%<small>8% false +</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">Confirmatory<br/>50%</div>
<div class="tree-node tp">PPV = 99%<small>1% false +</small></div>
</div>
</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "E il medico disse 'accurato al 99%'<br/>
                  e il paziente sentì 'certo al 99%'<br/>
                  ed entrambi furono ingannati—<br/>
                  perché si erano dimenticati di chiedere: quanto è raro questo ?"
                </div>
</div>
</div>
</div>
<!-- ==================== MODULE 7: TB GeneXpert ==================== -->
<div class="module-slides" data-module="7">
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai sentito parlare della macchina<br/>
                  that could find TB in two hours,<br/>
                  che si chiamava <em>revolutionary</em>—<br/>
                  ma ti sei perso <em>drug-resistant</em> strains?
                </div>
</div>
</div>
<div class="slide tb">
<div class="content text-center">
<div class="title gold animate">La storia di GeneXpert, Sud Africa</div>
<div class="story-card animate delay-1">
<div class="place">CAPE TOWN, 2010</div>
<div class="narrative">
                    Per un secolo, la diagnosi della tubercolosi ha richiesto la crescita di batteri per settimane. Poi è arrivato GeneXpert: risultati in <strong>2 hours</strong>.
                    <br/><br/>
                    South Africa deployed it nationwide. The WHO endorsed it.
                    <br/><br/>
                    Ma nei pazienti con <strong>low bacterial loads</strong>—often HIV co-infected—
                    sensitivity dropped to <strong>67%</strong>. One in three cases missed.
                    <br/><br/>
                    E per rilevare la resistenza alla rifampicina, ha mancato <strong>5%</strong> casi resistenti. Quei pazienti hanno ricevuto il trattamento sbagliato. La diffusione della tubercolosi resistente.
                  </div>
<div class="source">Steingart KR et al. Cochrane Database Syst Rev. 2014;1:CD009593</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">TB Diagnosis Decision Tree</div>
<div class="decision-tree animate delay-1">
<h4>Quando GeneXpert non basta</h4>
<div class="tree-row"><div class="tree-node root">Suspected TB Patient</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node action">GeneXpert Test</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-node tp">Positive</div>
<div class="tree-arrow">↓</div>
<div class="tree-node question">Rifampicin?</div>
<div class="tree-branch" style="gap:0.3rem;">
<div class="tree-branch-item">
<div class="tree-node tp" style="font-size:0.55rem;">Sensitive<small>Standard Tx</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node fp" style="font-size:0.55rem;">Resistant<small>MDR-TB Tx</small></div>
</div>
</div>
</div>
<div class="tree-branch-item">
<div class="tree-node warning">Negative</div>
<div class="tree-arrow">↓</div>
<div class="tree-node question">HIV+ or High Suspicion?</div>
<div class="tree-branch" style="gap:0.3rem;">
<div class="tree-branch-item">
<div class="tree-node action" style="font-size:0.55rem;">Yes<small>Culture needed</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node tn" style="font-size:0.55rem;">No<small>Likely negative</small></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Sensitivity by Patient Type</div>
<div class="stats-grid animate delay-1">
<div class="stat-box" style="background:var(--green);">
<div class="stat-value" style="color:white;">98%</div>
<div class="stat-label">Smear-positive<br/>(high bacterial load)</div>
</div>
<div class="stat-box" style="background:var(--orange);">
<div class="stat-value" style="color:white;">67%</div>
<div class="stat-label">Smear-negative<br/>(low bacterial load)</div>
</div>
<div class="stat-box" style="background:var(--red);">
<div class="stat-value" style="color:white;">61%</div>
<div class="stat-label">HIV co-infected<br/>(immune suppressed)</div>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">THE LESSON</div>
<div class="simple-text">
                    La sensibilità di un test negli studi clinici potrebbe non corrispondere alla sua sensibilità nei pazienti.
                    <strong>Conosci la tua popolazione.</strong>
</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "E la macchina disse 'negativo,'<br/>
                  e il medico credette alla macchina,<br/>
                  e il paziente tornò a casa con la tubercolosi nei polmoni,<br/>
                  resistenza alla tosse nel mondo."
                </div>
</div>
</div>
</div>
 ==================== MODULO 8: CONTROVERSIA PSA ==================== 
<div class="module-slides" data-module="8">
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai sentito parlare del test per gli uomini<br/>
                  che ha scoperto tumori che avrebbe <em>never kill</em>,<br/>
                  e avrebbe portato a trattamenti che <em>destroyed lives</em>?
                </div>
</div>
</div>
<div class="slide blood">
<div class="content text-center">
<div class="title red animate">La tragedia dello screening del PSA</div>
<div class="story-card animate delay-1">
<div class="place">UNITED STATES, 1990s-2010s</div>
<div class="narrative">
                    PSA (Prostate-Specific Antigen) could detect prostate cancer early.
                    <br/><br/>
                    I medici hanno sottoposto a screening milioni di uomini. Sono stati trovati tumori. Le prostate furono rimosse.
                    <br/><br/>
                    Ma molti di questi "tumori" non avrebbero mai causato sintomi. L'intervento ha causato <strong>impotenza e incontinenza</strong> in men who
                    <strong>would have died of old age, not cancer</strong>.
                  </div>
<div class="source">Moyer VA. Ann Intern Med. 2012;157:120-134</div>
</div>
<div class="story-box animate delay-2" style="margin-top:1rem;">
<div class="decision-tree">
<div class="decision-tree-header">Il dilemma dello screening del PSA: 2012</div>
<div class="decision-scenario">Un uomo di 60 anni chiede al suo medico informazioni sullo screening del PSA. Il PSA al cut-off di 4,0 ng/mL ha una sensibilità di circa il 21% per il cancro ad alto grado, ma rileva molti tumori indolenti.</div>
<div class="decision-paths">
<div class="decision-path path-a" role="button" tabindex="0">
<div class="path-label">PATH A: Screen All Men</div>
<div class="path-choice">Screening di routine del PSA per tutti gli uomini sopra i 50 anni</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Per 1.000 sottoposti a screening in 13 anni: 1-2 decessi prevenuti, ma oltre 100 falsi allarmi e 30-40 uomini rimasti impotenti o incontinenti a causa del trattamento di tumori indolenti</div>
<div class="path-outcome">OUTCOME: Net harm exceeds benefit at population level</div>
</div>
<div class="decision-path path-b" role="button" tabindex="0">
<div class="path-label">PATH B: Shared Decision-Making</div>
<div class="path-choice">Discutere i danni rispetto ai benefici; individualizzare con fattori di rischio, aspettativa di vita e valori del paziente</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">High-risk men can choose screening; low-risk men can decline; active surveillance replaces immediate surgery for low-grade findings</div>
<div class="path-outcome">OUTCOME: Fewer unnecessary treatments; patient autonomy preserved</div>
</div>
</div>
</div>
<div class="story-revelation">
<div class="revelation-label">THE REVELATION</div>
<div class="revelation-text">Un test con tassi di rilevamento elevati può causare più danni che benefici quando rileva condizioni che non necessitano di essere trovate. La sovradiagnosi è il costo nascosto dell'elevata sensibilità nella malattia indolente.</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">I numeri del danno</div>
<div class="stats-grid animate delay-1">
<div class="stat-box" style="background:var(--green);">
<div class="stat-value" style="color:white;">1</div>
<div class="stat-label">Vita salvata dallo<br/>prostate cancer<br/>per 1000 screened</div>
</div>
<div class="stat-box" style="background:var(--red);">
<div class="stat-value" style="color:white;">30-40</div>
<div class="stat-label">Men made impotent<br/>or incontinent<br/>per 1000 screened</div>
</div>
<div class="stat-box" style="background:var(--orange);">
<div class="stat-value" style="color:white;">100+</div>
<div class="stat-label">False positives<br/>(biopsies, anxiety)<br/>per 1000 screened</div>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">THE REVERSAL</div>
<div class="simple-text">
                    In 2012, the US Preventive Services Task Force recommended <strong>against</strong>
                    screening PSA di routine. Il test stava rilevando troppe cose che non era necessario trovare.
                  </div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Patient Decision Aid: PSA Screening</div>
<div class="decision-aid animate delay-1">
<h4>Se 1.000 uomini di età compresa tra 55 e 69 anni vengono sottoposti a screening per 13 anni</h4>
<div class="decision-aid-row">
<div class="decision-aid-label">Deaths from prostate cancer prevented</div>
<div class="decision-aid-value benefit">1-2 men</div>
</div>
<div class="decision-aid-row">
<div class="decision-aid-label">Men who will have false positive requiring biopsy</div>
<div class="decision-aid-value harm">100-120 men</div>
</div>
<div class="decision-aid-row">
<div class="decision-aid-label">Uomini a cui è stato diagnosticato un cancro che non farebbe mai loro del male</div>
<div class="decision-aid-value harm">20-50 men</div>
</div>
<div class="decision-aid-row">
<div class="decision-aid-label">Men left impotent or incontinent from treatment</div>
<div class="decision-aid-value harm">30-40 men</div>
</div>
<div class="decision-aid-question">È questo compromesso accettabile per te?</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "E il test ha trovato l'ombra,<br/>
                  e il chirurgo tagliato,<br/>
                  e l'uomo viveva – impotente, incontinente –<br/>
                  da un cancro che non si sarebbe mai risvegliato."
                </div>
</div>
</div>
</div>
 ==================== MODULO 9: TROPONINA E ATTACCHI DI CUORE ==================== 
<div class="module-slides" data-module="9">
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai sentito parlare dell'uomo con dolore al petto<br/>
                  la cui prima troponina era <em>normal</em>,<br/>
                  che fu mandato a casa—<br/>
                  e morì prima mattina?
                </div>
</div>
</div>
<div class="slide blood">
<div class="content text-center">
<div class="title red animate">Il problema della tempistica della troponina</div>
<div class="story-card animate delay-1">
<div class="place">EMERGENCY DEPARTMENTS WORLDWIDE</div>
<div class="narrative">
                    La troponina è il gold standard per la diagnosi di infarto. Ma ci vuole <strong>3-6 hours</strong> to rise after myocardial injury.
                    <br/><br/>
                    A patient arrives one hour after chest pain begins.
                    Troponin is tested: <strong>normal</strong>.
                    "You're fine. Go home."
                    <br/><br/>
                    Il cuore stava morendo. La proteina non era ancora fuoriuscita.
                    <br/><br/>
                    Studies show <strong>2-5%</strong> of MI patients sent home from ED die within 30 days.
                  </div>
<div class="source">Pope JH et al. N Engl J Med. 2000;342:1163-1170</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Serial Testing Decision Tree</div>
<div class="decision-tree animate delay-1">
<h4>Il protocollo delle due troponine</h4>
<div class="tree-row"><div class="tree-node root">Chest Pain Patient</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node action">First Troponin</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-node tp">Elevated</div>
<div class="tree-arrow">↓</div>
<div class="tree-node action">Treat as MI</div>
</div>
<div class="tree-branch-item">
<div class="tree-node warning">Normal</div>
<div class="tree-arrow">↓</div>
<div class="tree-node question">When Did Pain Start?</div>
<div class="tree-branch" style="gap:0.3rem;">
<div class="tree-branch-item">
<div class="tree-label">&lt;6 hrs</div>
<div class="tree-node action" style="font-size:0.55rem;">Wait 3 hrs<small>Repeat troponin</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">&gt;6 hrs</div>
<div class="tree-node tn" style="font-size:0.55rem;">Low risk<small>Consider d/c</small></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">High-Sensitivity Troponin</div>
<div class="stats-grid animate delay-1">
<div class="stat-box">
<div class="stat-value" style="color:var(--orange);">~70%</div>
<div class="stat-label">Conventional troponin<br/>sensitivity at 0 hrs</div>
</div>
<div class="stat-box">
<div class="stat-value" style="color:var(--green);">~95%</div>
<div class="stat-label">hs-Troponin<br/>sensitivity at 0 hrs</div>
</div>
<div class="stat-box">
<div class="stat-value" style="color:var(--gold);">99%</div>
<div class="stat-label">hs-Troponin<br/>at 3 hrs serial</div>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">THE TRADE-OFF</div>
<div class="simple-text">
                    High-sensitivity troponin catches more heart attacks early.
                    But it also has more false positives—elevated in kidney disease,
                    heart failure, sepsis, and marathon runners.
                  </div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "E il test ha detto 'normale'<br/>
                  perché il cuore aveva appena iniziato a morire.<br/>
                  E il paziente era rassicurato,<br/>
                  and went home to finish dying."
                </div>
</div>
</div>
</div>
 ==================== MODULO 10: RAPPORTI DI PROBABILITÀ ==================== 
<div class="module-slides" data-module="10">
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  La sensibilità descrive il test.<br/>
                  La specificità descrive il test.<br/>
<br/>
                  Ma il paziente chiede:<br/>
<em>"I tested positive. What are MY chances?"</em>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="story-box animate">
<p class="story-opener">E se la sensibilità pubblicata di un test fosse superiore alla verità e i rapporti di verosimiglianza calcolati fossero quindi errati?</p>
<div class="real-data-box">
<h4>REAL DATA</h4>
<p>Rapid strep tests (RADT) showed pooled sensitivity of approximately <span class="data-highlight">86%</span> negli studi pubblicati inclusi nelle revisioni Cochrane. Tuttavia, le richieste normative della FDA 510(k), che includono dati non pubblicati del produttore, hanno rivelato stime di sensibilità di soli <span class="data-highlight">70-75%</span>. Gli studi pubblicati con sensibilità più elevata avevano maggiori probabilità di essere inviati per la pubblicazione: un classico caso di bias di pubblicazione che ne gonfia l'accuratezza apparente.</p>
</div>
<div class="decision-tree">
<div class="decision-tree-header">The Rapid Strep Test Publication Gap</div>
<div class="decision-scenario">Un medico calcola LR+ dai dati pubblicati (sensibilità 86%, specificità 95%) per decidere se trattare il mal di gola di un bambino. Ma la vera sensibilità può essere solo del 70%.</div>
<div class="decision-paths">
<div class="decision-path path-a" role="button" tabindex="0">
<div class="path-label">PATH A: Trust Published Meta-Analysis</div>
<div class="path-choice">Utilizzare LR+ dai dati pubblicati (86/5 = 17,2)</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Lr+ sovrastimato porta a un'eccessiva fiducia in un risultato negativo; i bambini affetti da streptococco vengono mandati a casa senza antibiotici</div>
<div class="path-outcome">OUTCOME: Missed strep leads to rheumatic fever risk</div>
</div>
<div class="decision-path path-b" role="button" tabindex="0">
<div class="path-label">PERCORSO B: ricerca di dati normativi</div>
<div class="path-choice">Utilizzare LR+ dalle proposte della FDA (70/5 = 14) e notare che LR- è peggiore (0,32 vs 0,15)</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Recognize a negative RADT cannot confidently exclude strep; back up with throat culture when clinical suspicion is high</div>
<div class="path-outcome">OUTCOME: Appropriate caution protects children</div>
</div>
</div>
</div>
<div class="story-revelation">
<div class="revelation-label">THE REVELATION</div>
<div class="revelation-text">I rapporti di verosimiglianza sono onesti tanto quanto la sensibilità e la specificità che li producono. I bias di pubblicazione gonfiano l’accuratezza, rendendo LR+ troppo ottimista e LR- troppo rassicurante. Chiediti sempre: mancano studi non pubblicati?</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Likelihood Ratios</div>
<div class="formula-box animate delay-1">
<div class="label">POSITIVE LIKELIHOOD RATIO</div>
<div class="formula">LR+ = Sensitivity / (1 - Specificity)</div>
<div class="label">How much more likely is a + result in sick vs healthy?</div>
</div>
<div class="formula-box animate delay-2">
<div class="label">NEGATIVE LIKELIHOOD RATIO</div>
<div class="formula">LR- = (1 - Sensitivity) / Specificity</div>
<div class="label">How much more likely is a - result in sick vs healthy?</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Il Fagan Nomogramma</div>
<div class="fagan-container animate delay-1">
<h4>Dalla probabilità pre-test a quella post-test</h4>
<div class="fagan-visual">
<div class="fagan-scale">
<div class="fagan-scale-title">Pre-Test<br/>Probability</div>
<div>99%</div><div>50%</div><div>20%</div><div>5%</div><div>1%</div>
</div>
<div class="fagan-line"><div class="fagan-marker" style="top:70%;"></div></div>
<div class="fagan-scale">
<div class="fagan-scale-title">Likelihood<br/>Ratio</div>
<div>100</div><div>10</div><div>1</div><div>0.1</div><div>0.01</div>
</div>
<div class="fagan-line"><div class="fagan-marker" style="top:30%;"></div></div>
<div class="fagan-scale">
<div class="fagan-scale-title">Post-Test<br/>Probability</div>
<div>99%</div><div>80%</div><div>50%</div><div>20%</div><div>1%</div>
</div>
</div>
<div class="fagan-result">
                    Draw a line from pre-test through LR to find post-test probability
                  </div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Interpreting Likelihood Ratios</div>
<div class="decision-tree animate delay-1">
<h4>Quanto è potente questo test?</h4>
<div class="tree-row"><div class="tree-node question">LR+ Value?</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-node tp">LR+ &gt; 10<small>Strong rule-in</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node action">5-10<small>Moderate</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node warning">2-5<small>Weak</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node fn">1-2<small>Useless</small></div>
</div>
</div>
<div style="margin-top:0.75rem;"></div>
<div class="tree-row"><div class="tree-node question">LR- Value?</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-node tp">&lt; 0.1<small>Strong rule-out</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node action">0.1-0.2<small>Moderate</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node warning">0.2-0.5<small>Weak</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node fn">0.5-1<small>Useless</small></div>
</div>
</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain animate">
                  "La sensibilità racconta dei malati.<br/>
                  La specificità racconta dei malati bene.<br/>
                  But the likelihood ratio answers:<br/>
<em>Cosa significa questo risultato per QUESTO paziente?</em>"
                </div>
</div>
</div>
</div>
 ==================== MODULO 11: RDT MALARIA ==================== 
<div class="module-slides" data-module="11">
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai visto il bambino con la febbre nel villaggio,<br/>
                  il test rapido detto questo <em>negative</em>,<br/>
                  and the <em>Plasmodium</em> che continuava a moltiplicarsi?
                </div>
</div>
</div>
<div class="slide blood">
<div class="content text-center">
<div class="title red animate">Il problema dell'RDT sulla malaria</div>
<div class="story-card animate delay-1">
<div class="place">SUB-SAHARAN AFRICA</div>
<div class="narrative">
                    Malaria kills 600,000 people yearly, mostly children under 5.
                    <br/><br/>
                    Rapid Diagnostic Tests were meant to guide treatment in remote areas
                    without microscopes or laboratories.
                    <br/><br/>
                    But when parasitemia is low—<strong>l'RDT non rileva i casi</strong>.
                    And when <em>P. falciparum</em> elimina il gene HRP2—
                    <strong>the RDT sees nothing at all</strong>.
                  </div>
<div class="source">WHO. Malaria RDT Performance. 2022</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La decisione clinica Albero</div>
<div class="decision-tree animate delay-1">
<h4>Child with Fever in Malaria-Endemic Area</h4>
<div class="tree-row"><div class="tree-node root">Febrile Child</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node action">Perform RDT</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-node tp">RDT Positive</div>
<div class="tree-arrow">↓</div>
<div class="tree-node action">Trattamento per la malaria</div>
</div>
<div class="tree-branch-item">
<div class="tree-node warning">RDT Negative</div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node question">Clinical Suspicion?</div></div>
<div class="tree-branch" style="gap:0.4rem;">
<div class="tree-branch-item">
<div class="tree-label">High</div>
<div class="tree-node action" style="font-size:0.55rem;">Treat Anyway<small>or Microscopy</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">Low</div>
<div class="tree-node tn" style="font-size:0.55rem;">Look for<small>Other Cause</small></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Sensitivity Varies by Parasitemia</div>
<div class="stats-grid animate delay-1">
<div class="stat-box" style="background:var(--green);">
<div class="stat-value" style="color:white;">95%</div>
<div class="stat-label">High parasitemia<br/>(&gt;200/μL)</div>
</div>
<div class="stat-box" style="background:var(--gold);">
<div class="stat-value" style="color:var(--navy);">75%</div>
<div class="stat-label">Low parasitemia<br/>(100-200/μL)</div>
</div>
<div class="stat-box" style="background:var(--red);">
<div class="stat-value" style="color:white;">50%</div>
<div class="stat-label">Very low<br/>(&lt;100/μL)</div>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">LA LEZIONE CLINICA</div>
<div class="simple-text">
                    A negative RDT does not rule out malaria in endemic areas.
                    <strong>Clinical judgment must override the test</strong> when suspicion is high.
                  </div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "E il test ha dato 'negativo'<br/>
                  e il bambino fu mandato a casa,<br/>
                  e i parassiti si moltiplicarono nell'oscurità,<br/>
                  e al mattino il bambino non poteva più wake."
                </div>
</div>
</div>
</div>
 ==================== MODULO 12: TEST RAPIDI COVID ==================== 
<div class="module-slides" data-module="12">
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Nell'anno della pestilenza,<br/>
                  il mondo aveva bisogno di un test che era <em>fast</em>.
                  <br/><br/>
                  Ma veloce non è la stessa cosa di <em>accurate</em>.
                </div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="story-box animate">
<p class="story-opener">Quando arriva una nuova generazione di test con una sensibilità più elevata, questo lo migliora automaticamente?</p>
<div class="real-data-box">
<h4>REAL DATA</h4>
<p>I test della troponina ad alta sensibilità (hs-cTn) hanno aumentato la sensibilità per l'infarto miocardico acuto da circa <span class="data-highlight">70%</span> (troponina convenzionale a presentazione) a over <span class="data-highlight">95%</span>. But specificity dropped from approximately <span class="data-highlight">95%</span> to around <span class="data-highlight">80%</span> perché hs-cTn rileva il danno miocardico da molte cause non-IM (insufficienza cardiaca, sepsi, malattia renale, embolia polmonare). L'effetto clinico netto ha richiesto la modellazione HSROC in più studi per comprendere il compromesso.</p>
</div>
<div class="decision-tree">
<div class="decision-tree-header">Il cambiamento nella generazione della troponina: anni 2010</div>
<div class="decision-scenario">An emergency department adopts hs-troponin. More patients now test positive, but many do not have acute MI.</div>
<div class="decision-paths">
<div class="decision-path path-a" role="button" tabindex="0">
<div class="path-label">PATH A: Adopt Based on Sensitivity Alone</div>
<div class="path-choice">Celebrare che il rilevamento dell'IM è passato dal 70% a oltre il 95%</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Un numero maggiore di falsi positivi porta a cateterizzazioni non necessarie, ricoveri ospedalieri, e ansia del paziente per aumenti della troponina non cardiaci</div>
<div class="path-outcome">OUTCOME: Overdiagnosis and wasted resources</div>
</div>
<div class="decision-path path-b" role="button" tabindex="0">
<div class="path-label">PERCORSO B: modellare il compromesso</div>
<div class="path-choice">Use serial measurements (0h/1h or 0h/3h protocols) and clinical context to maintain specificity</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Rapid rule-out algorithms safely discharge low-risk patients; sensitivity remains high while managing the false positive rate</div>
<div class="path-outcome">OUTCOME: Faster, safer triage of chest pain</div>
</div>
</div>
</div>
<div class="story-revelation">
<div class="revelation-label">THE REVELATION</div>
<div class="revelation-text">Sensibilità e specificità si compensano a vicenda. Una nuova generazione di test che aumenta la sensibilità spesso riduce la specificità. La curva HSROC è lo strumento che rivela se il compromesso netto aiuta o danneggia i pazienti.</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Il verdetto Cochrane</div>
<div class="matrix-container animate delay-1">
<h4>COVID-19 Rapid Antigen Tests (Dinnes 2022 Cochrane Review)</h4>
<table class="matrix-table">
<tr><th>Population</th><th>Sensitivity</th><th>Missed</th></tr>
<tr><td>Symptomatic</td><td style="color:var(--gold);">73%</td><td style="color:var(--red);">27%</td></tr>
<tr><td>Asymptomatic</td><td style="color:var(--orange);">55%</td><td style="color:var(--red);">45%</td></tr>
<tr><td>First 7 days</td><td style="color:var(--green);">80%</td><td style="color:var(--orange);">20%</td></tr>
</table>
</div>
<p class="animate delay-2" style="font-size:0.65rem;color:rgba(255,255,255,0.5);margin-top:0.4rem;">
                  Dinnes J et al. Cochrane Database Syst Rev. 2022;7:CD013705
                </p>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">The False Security Decision Tree</div>
<div class="decision-tree animate delay-1">
<h4>Thanksgiving 2020: What Happened</h4>
<div class="tree-row"><div class="tree-node root">Family Member Tests Negative</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node question">Truly Negative?</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-label">55% if asymptomatic</div>
<div class="tree-node tn">True Negative<small>Safe to gather</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">45% if asymptomatic</div>
<div class="tree-node fn">FALSE Negative<small>Infectious!</small></div>
<div class="tree-arrow">↓</div>
<div class="tree-node fp" style="background:var(--blood-red);">Si riunisce con la famiglia<small>Grandparents infected</small></div>
</div>
</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "E il test ha dato 'negativo'<br/>
                  e la famiglia abbracciato,<br/>
                  e alla fine dell'inverno,<br/>
                  il nonno fu sepolto."
                </div>
</div>
</div>
</div>
<!-- ==================== MODULE 13: MAMMOGRAPHY ==================== -->
<div class="module-slides" data-module="13">
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai sentito parlare dello screening<br/>
                  che ha scoperto tumori che <em>would never kill</em>,<br/>
                  e avrebbe portato a trattamenti che <em>caused more harm than the disease</em>?
                </div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="story-box animate">
<p class="story-opener">Can you trust a DTA meta-analysis done in a spreadsheet?</p>
<div class="real-data-box">
<h4>REAL DATA</h4>
<p>La meta-analisi DTA richiede il modello bivariato o HSROC: entrambi necessitano di una stima della massima verosimiglianza della sensibilità e specificità correlate sulla scala logit. La ricerca ha documentato che i calcoli manuali di Excel introducono spesso errori: uno studio fondamentale di Reinhart &amp; Rogoff (2010, economia) ha dimostrato come un semplice errore nel foglio di calcolo abbia portato a cambiamenti politici globali. In DTA, l'applicazione manuale delle trasformazioni logit e il raggruppamento di sensibilità/specificità separatamente in Excel ignora la correlazione tra di loro e può produrre stime aggregate che differiscono in modo significativo dai modelli bivariati convalidati nel software (R mada/reitsma, Stata metandi, SAS NLMIXED).</p>
</div>
<div class="decision-tree">
<div class="decision-tree-header">L'errore QUADAS Excel</div>
<div class="decision-scenario">Un gruppo di ricerca ha bisogno di sensibilità e specificità per una revisione sistematica DTA. Hanno 12 studi. Un membro del team crea un modello Excel; un altro utilizza il pacchetto mada di R.</div>
<div class="decision-paths">
<div class="decision-path path-a" role="button" tabindex="0">
<div class="path-label">PERCORSO A: utilizza il foglio di calcolo</div>
<div class="path-choice">Pool sensitivity and specificity separately in Excel using simple averages or fixed-effect formulas</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Ignora la correlazione tra sensibilità e specificità; composti degli errori di trasformazione logit; sensibilità raggruppata di circa 12 punti percentuali</div>
<div class="path-outcome">OUTCOME: Wrong numbers published; clinical guidelines misled</div>
</div>
<div class="decision-path path-b" role="button" tabindex="0">
<div class="path-label">PATH B: Use Validated Software</div>
<div class="path-choice">Utilizzare R (mada/reitsma), Stata (metandi) o SAS (NLMIXED) con il modello bivariato</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Il GLMM bivariato corretto tiene conto del compromesso sensibilità-specificità, produce regioni di confidenza valide e gestisce gli studi tra studi eterogeneità</div>
<div class="path-outcome">OUTCOME: Reproducible, auditable, correct results</div>
</div>
</div>
</div>
<div class="story-revelation">
<div class="revelation-label">THE REVELATION</div>
<div class="revelation-text">la meta-analisi DTA non è un semplice raggruppamento. La natura bivariata dei dati (sensibilità e specificità accoppiate) richiede un software statistico specializzato. Un errore nel foglio di calcolo non è solo un inconveniente: può cambiare la pratica clinica.</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La sovradiagnosi Problema</div>
<div class="stats-grid animate delay-1">
<div class="stat-box" style="background:var(--green);">
<div class="stat-value" style="color:white;">3-4</div>
<div class="stat-label">Lives saved<br/>per 10,000 screened</div>
</div>
<div class="stat-box" style="background:var(--red);">
<div class="stat-value" style="color:white;">50-130</div>
<div class="stat-label">Overdiagnosed<br/>(treated unnecessarily)</div>
</div>
<div class="stat-box" style="background:var(--orange);">
<div class="stat-value" style="color:white;">~500</div>
<div class="stat-label">False alarms<br/>(anxiety, biopsies)</div>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">THE QUESTION</div>
<div class="simple-text">
                    Per salvare 3-4 vite, circa 50-130 donne vengono sottoposte a intervento chirurgico, radioterapia o chemioterapia per tumori che non avrebbero mai potuto danneggiarle.
                    <br/><br/><strong>Vale la pena questo compromesso?</strong>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Patient Decision Aid: Mammography</div>
<div class="decision-aid animate delay-1">
<h4>Se 10.000 donne di età compresa tra 50 e 69 anni vengono sottoposte a screening per 10 anni</h4>
<div class="decision-aid-row">
<div class="decision-aid-label">Deaths from breast cancer prevented</div>
<div class="decision-aid-value benefit">3-4 women</div>
</div>
<div class="decision-aid-row">
<div class="decision-aid-label">Women called back for false alarms</div>
<div class="decision-aid-value harm">~500 women</div>
</div>
<div class="decision-aid-row">
<div class="decision-aid-label">Unnecessary biopsies</div>
<div class="decision-aid-value harm">~200 women</div>
</div>
<div class="decision-aid-row">
<div class="decision-aid-label">Donne curate per un cancro che non farebbe mai loro del male</div>
<div class="decision-aid-value harm">~15 women</div>
</div>
<div class="decision-aid-question">Lo screening è adatto a te?</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">The Screening Cascade Decision Tree</div>
<div class="decision-tree animate delay-1">
<h4>10.000 donne sottoposte a screening in oltre 10 Anni</h4>
<div class="tree-row"><div class="tree-node root">10,000 Women</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-node warning">~1,000 Recalled<small>Abnormal</small></div>
<div class="tree-arrow">↓</div>
<div class="tree-branch" style="gap:0.25rem;">
<div class="tree-branch-item">
<div class="tree-node fp" style="font-size:0.5rem;">~500 False<br/>Alarm</div>
</div>
<div class="tree-branch-item">
<div class="tree-node warning" style="font-size:0.5rem;">~500 Biopsy<br/>~50 cancer</div>
</div>
</div>
</div>
<div class="tree-branch-item">
<div class="tree-node tn">~9,000 Cleared</div>
</div>
</div>
<div style="margin-top:0.4rem;">
<div class="tree-row"><div class="tree-node question" style="font-size:0.6rem;">Of ~50 Cancers Found</div></div>
<div class="tree-branch" style="gap:0.5rem;">
<div class="tree-branch-item">
<div class="tree-node tp" style="font-size:0.5rem;">~35 Would Kill<small>3-4 saved</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node fn" style="font-size:0.5rem;">~15 Would Never Kill<small>Overdiagnosed</small></div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "E il test ha trovato l'ombra,<br/>
                  e lo chiamavano cancro,<br/>
                  e la donna veniva tagliata e bruciata—<br/>
                  per un'ombra che non l'avrebbe mai oscurata giorni."
                </div>
</div>
</div>
</div>
 ==================== MODULO 14: AMILOIDE DI ALZHEIMER ==================== 
<div class="module-slides" data-module="14">
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai sentito parlare della scansione<br/>
                  che trova le placche nel cervello,<br/>
                  ma non puoi dirti<br/>
                  se mente volontà <em>fade</em>?
                </div>
</div>
</div>
<div class="slide gradient">
<div class="content text-center">
<div class="title gold animate">Il paradosso dell'amiloide</div>
<div class="story-card animate delay-1">
<div class="place">ALZHEIMER'S RESEARCH, 2010s-2020s</div>
<div class="narrative">
                    PET scans can now detect amyloid plaques—the hallmark of Alzheimer's.
                    <br/><br/>
                    But <strong>30% of cognitively normal elderly</strong> have amyloid plaques.
                    They may never develop dementia.
                    <br/><br/>
                    And <strong>10-20% delle persone affette da demenza</strong> have no amyloid.
                    <br/><br/>
                    Il test rileva le placche, ma le placche non sono la malattia.
                    <strong>Stiamo testando un surrogato, non il. risultato.</strong>
</div>
<div class="source">Jack CR et al. Lancet Neurol. 2018;17:760-773</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Surrogate vs. Outcome Decision Tree</div>
<div class="decision-tree animate delay-1">
<h4>Che cosa stiamo realmente analizzando?</h4>
<div class="tree-row"><div class="tree-node root">Diagnostic Test</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node question">What Does It Detect?</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-label">Outcome itself</div>
<div class="tree-node tp">Direct Diagnosis<small>ad esempio, biopsia per il cancro</small></div>
<div class="tree-arrow">↓</div>
<div class="tree-node action">High clinical value</div>
</div>
<div class="tree-branch-item">
<div class="tree-label">Surrogate marker</div>
<div class="tree-node warning">Indirect Signal<small>ad esempio, amiloide per la demenza</small></div>
<div class="tree-arrow">↓</div>
<div class="tree-node question">Validated link?</div>
<div class="tree-branch" style="gap:0.3rem;">
<div class="tree-branch-item">
<div class="tree-node action" style="font-size:0.5rem;">Yes<small>Use cautiously</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node fn" style="font-size:0.5rem;">No<small>Limited value</small></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "E la scansione ha trovato il placche,<br/>
                  e il medico lo chiamò Alzheimer,<br/>
                  e il paziente viveva nel terrore—<br/>
                  of a forgetting that might never come."
                </div>
</div>
</div>
</div>
 ==================== MODULO 15: QUALITÀ QUADAS-2 ==================== 
<div class="module-slides" data-module="15">
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non tutti gli studi sono uguali.
                  <br/><br/>
                  Some are <em>biased</em>.<br/>
                  Some are <em>poorly designed</em>.<br/>
                  Alcuni non dovrebbero esserlo <em>trusted</em>.
                  <br/><br/>
                  Come separiamo il grano dalla pula?
                </div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="story-box animate">
<p class="story-opener">E se la maggior parte degli studi DTA non riportassero nemmeno informazioni sufficienti per giudicare i loro risultati? qualità?</p>
<div class="real-data-box">
<h4>REAL DATA</h4>
<p>Prima che l'iniziativa STARD fosse pubblicata nel 2003, una valutazione sistematica ha rilevato che meno di <span class="data-highlight">half</span> degli studi DTA riportavano se l'interpretazione del test indice era in cieco e le descrizioni degli standard di riferimento erano spesso inadeguate. Dopo STARD, la segnalazione è migliorata: molteplici valutazioni meta-epidemiologiche hanno rilevato che l'adesione agli elementi STARD è aumentata sostanzialmente, sebbene molti studi non fossero ancora all'altezza degli elementi chiave come i diagrammi di flusso e la gestione indeterminata dei risultati.</p>
</div>
<div class="decision-tree">
<div class="decision-tree-header">La rivoluzione STARD: 2003</div>
<div class="decision-scenario">Un team completa uno studio DTA di un nuovo test point-of-care. Sono ansiosi di pubblicare rapidamente. Dispongono dei dati 2x2 ma non hanno documentato l'accecamento, il flusso dei pazienti o risultati indeterminati.</div>
<div class="decision-paths">
<div class="decision-path path-a" role="button" tabindex="0">
<div class="path-label">PATH A: Publish Quickly</div>
<div class="path-choice">Invia senza un diagramma di flusso STARD o un reporting completo dei metodi</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">I lettori non possono valutare l'accecamento, lo spettro dei pazienti o la verifica. La valutazione QUADAS-2 valuta ogni dominio come "poco chiaro". Lo studio potrebbe essere escluso da future revisioni sistematiche o, peggio, incluso con un peso gonfiato.</div>
<div class="path-outcome">OUTCOME: Waste of research; uninterpretable results</div>
</div>
<div class="decision-path path-b" role="button" tabindex="0">
<div class="path-label">PATH B: Follow STARD Guidelines</div>
<div class="path-choice">Completa la checklist STARD, crea un diagramma di flusso del paziente, riporta risultati indeterminati e descrivi l'accecamento</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">I revisori possono valutare pienamente la qualità. I domini QUADAS-2 sono responsabili. Lo studio contribuisce in modo significativo alle revisioni sistematiche e alle linee guida cliniche.</div>
<div class="path-outcome">RISULTATO: prove affidabili che fanno avanzare la cura</div>
</div>
</div>
</div>
<div class="story-revelation">
<div class="revelation-label">THE REVELATION</div>
<div class="revelation-text">Non è possibile valutare la qualità se lo studio non riporta i suoi metodi. STARD garantisce che gli studi DTA siano sufficientemente completi per essere giudicati da QUADAS-2. Un reporting incompleto non è neutrale: nasconde pregiudizi.</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">QUADAS-2: La lista di controllo della qualità</div>
<div class="quadas-container animate delay-1">
<h4>Four Domains of Risk of Bias</h4>
<div class="quadas-domain">
<div class="quadas-icon risk">1</div>
<div class="quadas-content">
<h5>Patient Selection</h5>
<p>È stato arruolato un campione consecutivo o casuale? È stato evitato un disegno caso-controllo?</p>
</div>
</div>
<div class="quadas-domain">
<div class="quadas-icon risk">2</div>
<div class="quadas-content">
<h5>Index Test</h5>
<p>Il test è stato interpretato senza conoscere la norma di riferimento? La soglia è stata pre-specificata?</p>
</div>
</div>
<div class="quadas-domain">
<div class="quadas-icon risk">3</div>
<div class="quadas-content">
<h5>Reference Standard</h5>
<p>È probabile che lo standard di riferimento classifichi correttamente la condizione? È stato interpretato alla cieca?</p>
</div>
</div>
<div class="quadas-domain">
<div class="quadas-icon concern">4</div>
<div class="quadas-content">
<h5>Flusso e tempistiche</h5>
<p>C'era un intervallo appropriato tra i test? Tutti i pazienti hanno ricevuto lo stesso standard di riferimento?</p>
</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">QUADAS-2 Decision Tree</div>
<div class="decision-tree animate delay-1">
<h4>Dovreste fidarvi di questo studio?</h4>
<div class="tree-row"><div class="tree-node root">DTA Study</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node question">Check All 4 Domains</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-label">All Low Risk</div>
<div class="tree-node tp">High Quality<small>Trust results</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">Some Unclear</div>
<div class="tree-node warning">Moderate<small>Utilizzare con cautela</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">Any High Risk</div>
<div class="tree-node fp">Low Quality<small>I risultati potrebbero essere distorti</small></div>
</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Distorsioni comuni nella DTA Studi</div>
<div class="lesson-item animate delay-1">
<div class="lesson-number" style="background:var(--red);">!</div>
<div class="lesson-content">
<h4>Verification Bias</h4>
<p>Only positive tests get the reference standard → inflates sensitivity</p>
</div>
</div>
<div class="lesson-item animate delay-2">
<div class="lesson-number" style="background:var(--red);">!</div>
<div class="lesson-content">
<h4>Spectrum Bias</h4>
<p>La popolazione studiata differisce dalla realtà clinica → i risultati non si generalizzano</p>
</div>
</div>
<div class="lesson-item animate delay-3">
<div class="lesson-number" style="background:var(--orange);">!</div>
<div class="lesson-content">
<h4>Incorporation Bias</h4>
<p>Index test is part of reference standard → artificially high accuracy</p>
</div>
</div>
<div class="lesson-item animate delay-4">
<div class="lesson-number" style="background:var(--orange);">!</div>
<div class="lesson-content">
<h4>Review Bias</h4>
<p>Index test interpreted knowing reference result → inflates both metrics</p>
</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain animate">
                  "Prima di fidarsi dei numeri,<br/>
                  ask: How were they gathered?<br/>
                  Uno studio parziale parla con sicurezza—<br/>
                  but its confidence is a lie."
                </div>
</div>
</div>
</div>
 ==================== MODULO 16: META-ANALISI E SROC ==================== 
<div class="module-slides" data-module="16">
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  Uno studio può ingannare.<br/>
                  Uno studio può lusingare.
                  <br/><br/>
                  Ma quando raccogli <em>tutti i prove</em>—<br/>
                  the truth becomes harder to hide.
                </div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="story-box animate">
<p class="story-opener">Cosa succede quando studi diversi utilizzano soglie diverse per lo stesso test e si tenta di metterle in comune?</p>
<div class="real-data-box">
<h4>REAL DATA</h4>
<p>D-dimer testing for pulmonary embolism (PE) traditionally used a fixed cutoff of <span class="data-highlight">500 µg/L</span>. Lo studio ADJUST-PE (Righini et al., JAMA 2014) ha dimostrato che un cut-off aggiustato per l'età (<span class="data-highlight">age × 10 µg/L</span> per pazienti sopra i 50 anni) ha aumentato la percentuale di pazienti anziani con risultati negativi per il D-dimero da <span class="data-highlight">~6% to ~30%</span>, con un rischio di TEV a 3 mesi di solo lo 0,3% nel gruppo negativo aggiustato per età. Una meta-analisi DTA degli studi sul D-dimero deve utilizzare il modello bivariato poiché soglie diverse creano un compromesso sensibilità-specificità visibile sulla curva SROC.</p>
</div>
<div class="decision-tree">
<div class="decision-tree-header">The D-dimer Threshold Dilemma: ADJUST-PE 2014</div>
<div class="decision-scenario">Un paziente anziano (75 anni) si presenta al pronto soccorso con possibile EP. Il D-dimero è 620 µg/L. Utilizzando il cutoff fisso, questo è positivo. Utilizzando il valore limite corretto per l'età (750 µg/L), questo è negativo.</div>
<div class="decision-paths">
<div class="decision-path path-a" role="button" tabindex="0">
<div class="path-label">PATH A: Use Fixed Cutoff (500 µg/L)</div>
<div class="path-choice">Apply one threshold to all patients regardless of age</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">I pazienti anziani superano quasi sempre i 500 µg/L. La specificità scende al di sotto del 10% negli ultraottantenni. Quasi tutti i pazienti anziani vengono sottoposti a un'angiografia polmonare TC, con mezzo di contrasto, radiazioni e reperti incidentali.</div>
<div class="path-outcome">OUTCOME: D-dimer becomes useless in the elderly</div>
</div>
<div class="decision-path path-b" role="button" tabindex="0">
<div class="path-label">PATH B: Use Bivariate Model with Threshold Covariate</div>
<div class="path-choice">Applicare il cut-off aggiustato per l'età; variazione della soglia del modello nella meta-analisi</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">La curva SROC mostra che le soglie adeguate all'età si muovono lungo la curva, scambiando una piccola quantità di sensibilità con un grande guadagno di specificità. Il 30% in più di pazienti anziani evita in modo sicuro l'imaging TC.</div>
<div class="path-outcome">OUTCOME: Fewer unnecessary scans; no missed PEs</div>
</div>
</div>
</div>
<div class="story-revelation">
<div class="revelation-label">THE REVELATION</div>
<div class="revelation-text">La variazione della soglia è la ragione per cui la meta-analisi DTA necessita del modello bivariato. Studi diversi utilizzano cut-off diversi, creando un compromesso tra sensibilità e specificità. La curva SROC è la mappa di questo compromesso.</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Why DTA Meta-Analysis Is Different</div>
<div class="simple-box animate delay-1">
<div class="simple-title">THE PROBLEM</div>
<div class="simple-text">
                    La sensibilità e la specificità sono <strong>correlated</strong>.
                    When one goes up, the other tends to go down.
                    <br/><br/>
                    Non è possibile raggrupparle separatamente come gli effetti del trattamento. Hai bisogno di <strong>bivariate model</strong>.
                  </div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La curva SROC</div>
<div class="sroc-container animate delay-1">
<h4>Summary Receiver Operating Characteristic</h4>
<div class="sroc-plot">
<div class="sroc-axis-label y">Sensitivity</div>
<div class="sroc-axis-label x">1 - Specificity (False Positive Rate)</div>
<svg class="sroc-curve" preserveaspectratio="none" viewbox="0 0 100 100">
<!-- Diagonal line (useless test) -->
<line stroke="rgba(255,255,255,0.2)" stroke-dasharray="4" stroke-width="1" x1="0" x2="100" y1="100" y2="0"></line>
<!-- SROC curve -->
<path d="M 5 5 Q 10 40, 30 60 Q 50 80, 95 95" fill="none" stroke="var(--gold)" stroke-width="3"></path>
<!-- Confidence region (simplified ellipse) -->
<ellipse cx="25" cy="25" fill="rgba(212,175,55,0.2)" rx="15" ry="10" stroke="var(--gold)" stroke-width="1"></ellipse>
</svg>
<!-- Study dots -->
<div class="sroc-dot" style="left:15%;top:20%;"></div>
<div class="sroc-dot" style="left:20%;top:25%;"></div>
<div class="sroc-dot" style="left:25%;top:22%;"></div>
<div class="sroc-dot" style="left:18%;top:28%;"></div>
<div class="sroc-dot" style="left:30%;top:30%;"></div>
</div>
<div class="sroc-legend">
<div class="sroc-legend-item"><div class="sroc-legend-dot" style="background:var(--gold);"></div>Individual studies</div>
<div class="sroc-legend-item"><div class="sroc-legend-dot" style="background:rgba(212,175,55,0.5);"></div>Summary estimate</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Leggere lo SROC</div>
<div class="decision-tree animate delay-1">
<h4>Cosa ti dice la curva?</h4>
<div class="tree-row"><div class="tree-node root">SROC Curve Position</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-label">Top-Left Corner</div>
<div class="tree-node tp">Excellent Test<small>High sens + spec</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">Near Diagonal</div>
<div class="tree-node fn">Useless Test<small>No better than chance</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">Points Scattered</div>
<div class="tree-node warning">High Heterogeneity<small>Investigate sources</small></div>
</div>
</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain hope animate">
                  "Uno studio può ingannare.<br/>
                  Molti studi, soppesati insieme,<br/>
                  tracciano il percorso della verità:<br/>
                  la curva SROC che rivela ciò che il test può veramente fare."
                </div>
</div>
</div>
</div>
<!-- ==================== MODULE 17: HETEROGENEITY ==================== -->
<div class="module-slides" data-module="17">
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  Ma cosa accadrebbe se gli studi <em>disagree</em>?
                  <br/><br/>
                  One says sensitivity is 95%.<br/>
                  Another says 60%.
                  <br/><br/>
<em>A quale verità credi?</em>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="story-box animate">
<p class="story-opener">E se un test funziona bene nella popolazione generale ma fallisce nei pazienti che ne hanno più bisogno?</p>
<div class="real-data-box">
<h4>REAL DATA</h4>
<p>HRP2-based malaria rapid diagnostic tests (RDTs) achieve sensitivity of approximately <span class="data-highlight">95%</span> in the general population in endemic areas. However, in pregnant women, sensitivity can drop to as low as <span class="data-highlight">56-76%</span> a causa del sequestro placentare dei parassiti: i parassiti si nascondono nella placenta, mantenendo la parassitemia del sangue periferico bassa e al di sotto della soglia di rilevamento RDT. Una revisione Cochrane degli RDT sulla malaria ha rilevato una sostanziale eterogeneità (I² spesso superiore all'80%) determinata da sottogruppi di popolazione tra cui gravidanza, bambini sotto i 5 anni e co-infezione da HIV.</p>
</div>
<div class="decision-tree">
<div class="decision-tree-header">L'RDT sulla malaria in gravidanza</div>
<div class="decision-scenario">Una meta-analisi raggruppa 25 studi RDT sulla malaria e riporta una sensibilità complessiva del 93%. Un medico in una clinica prenatale lo utilizza per rassicurare una donna incinta con un RDT negativo.</div>
<div class="decision-paths">
<div class="decision-path path-a" role="button" tabindex="0">
<div class="path-label">PATH A: Trust the Overall Pooled Estimate</div>
<div class="path-choice">Applicare la sensibilità del 93% ricavata dalla meta-analisi della popolazione generale</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Nelle donne in gravidanza, la sensibilità reale può essere pari al 56-76%. Una parte sostanziale delle donne incinte infette viene falsamente rassicurata. La malaria non trattata in gravidanza causa grave anemia materna, basso peso alla nascita e nati morti.</div>
<div class="path-outcome">OUTCOME: Preventable maternal and neonatal deaths</div>
</div>
<div class="decision-path path-b" role="button" tabindex="0">
<div class="path-label">PATH B: Investigate Heterogeneity by Subgroup</div>
<div class="path-choice">Condurre una meta-analisi di sottogruppi per le donne in gravidanza; esplorare I² e le fonti di variazione</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Scoprire che la gravidanza è una delle principali fonti di eterogeneità. Raccomandare la conferma microscopica per tutte le donne incinte con RDT negativi nelle aree endemiche.</div>
<div class="path-outcome">OUTCOME: Targeted protocols save mothers and babies</div>
</div>
</div>
</div>
<div class="story-revelation">
<div class="revelation-label">THE REVELATION</div>
<div class="revelation-text">L'eterogeneità non è solo rumore statistico. Spesso segnala che il test funziona in modo diverso nelle diverse popolazioni. Ignorare l'I² e mettere insieme tutto può essere fatale per i sottogruppi vulnerabili.</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Sources of Heterogeneity</div>
<div class="decision-tree animate delay-1">
<h4>Perché gli studi non concordano</h4>
<div class="tree-row"><div class="tree-node question">Stesso test, risultati diversi?</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-node warning">Threshold<small>Different cutoffs</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node warning">Population<small>Severity, age</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node warning">Setting<small>Primary vs specialist</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node warning">Quality<small>Bias, blinding</small></div>
</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Measuring Disagreement: I²</div>
<div class="stats-grid animate delay-1">
<div class="stat-box" style="background:var(--green);">
<div class="stat-value" style="color:white;">I² &lt; 25%</div>
<div class="stat-label">Low<br/>Studies agree</div>
</div>
<div class="stat-box" style="background:var(--gold);">
<div class="stat-value" style="color:var(--navy);">I² 25-75%</div>
<div class="stat-label">Moderate<br/>Some variation</div>
</div>
<div class="stat-box" style="background:var(--red);">
<div class="stat-value" style="color:white;">I² &gt; 75%</div>
<div class="stat-label">High<br/>Major disagreement</div>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">THE WARNING</div>
<div class="simple-text">
                    When I² &gt; 75%, the pooled estimate may be <strong>meaningless</strong>.
                    Explain the disagreement before averaging.
                  </div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "Quando gli studi sono in disaccordo,<br/>
                  non tacere il dissenso.<br/>
                  Ask: Why do they see differently?<br/>
                  Il disaccordo stesso insegna."
                </div>
</div>
</div>
</div>
 ==================== MODULO 18: IL TOOLKIT ==================== 
<div class="module-slides" data-module="18">
<div class="slide gradient active">
<div class="content text-center">
<div class="title gold animate">Il tuo DTA Toolkit</div>
<div class="subtitle animate delay-1">Le misure essenziali e quando utilizzarle</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="story-box animate">
<p class="story-opener">Quando un'intelligenza artificiale afferma di diagnosticare meglio dei medici, dovresti fidarti dell'AUC complessiva?</p>
<div class="real-data-box">
<h4>REAL DATA</h4>
<p>Deep learning models for skin cancer detection have reported AUC values as high as <span class="data-highlight">0.91-0.94</span> in development datasets. However, external validation revealed alarming disparities: Daneshjou et al. (<span class="data-highlight">2022</span>, Nature Medicine) ha scoperto che gli strumenti dermatologici di intelligenza artificiale commerciali hanno funzionato a livelli quasi casuali sulla pelle più scura (tipi Fitzpatrick V-VI), con un'AUC più bassa come <span class="data-highlight">0.50-0.57</span> — essenzialmente casuale. I set di dati di addestramento erano fortemente sbilanciati verso tonalità della pelle più chiare, il che significa che la tabella 2x2 non è mai stata compilata correttamente per tutte le popolazioni.</p>
</div>
<div class="decision-tree">
<div class="decision-tree-header">La promessa della dermatologia dell'intelligenza artificiale: anni 2020</div>
<div class="decision-scenario">Un ospedale considera l'implementazione di uno strumento di screening del cancro della pelle basato sull'intelligenza artificiale in una clinica dermatologica che serve una popolazione urbana diversificata. Il produttore riporta un'AUC di 0,94.</div>
<div class="decision-paths">
<div class="decision-path path-a" role="button" tabindex="0">
<div class="path-label">PATH A: Deploy Based on Overall AUC</div>
<div class="path-choice">Fidati dell'AUC del titolo di 0,94 e distribuiscilo a tutti i pazienti</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">I melanomi sulla pelle più scura vengono trascurati con tassi più elevati. Il dato complessivo sulla sensibilità nasconde un divario pericoloso. I pazienti con la più alta mortalità dovuta a diagnosi tardiva sono quelli in cui l'intelligenza artificiale fallisce maggiormente.</div>
<div class="path-outcome">OUTCOME: Health disparity amplified by technology</div>
</div>
<div class="decision-path path-b" role="button" tabindex="0">
<div class="path-label">PATH B: Demand Fairness-Stratified Evaluation</div>
<div class="path-choice">Richiedono sensibilità e specificità suddivise per tono della pelle (scala Fitzpatrick), età e posizione della lesione</div>
<div class="path-arrow">↓</div>
<div class="path-consequence">Scopri il divario di prestazioni. Richiedere la riqualificazione su set di dati diversi o limitare l'uso a popolazioni convalidate. Associa l'intelligenza artificiale alla supervisione di un dermatologo per i gruppi sottorappresentati.</div>
<div class="path-outcome">OUTCOME: Equitable deployment; no one left behind</div>
</div>
</div>
</div>
<div class="story-revelation">
<div class="revelation-label">THE REVELATION</div>
<div class="revelation-text">Un singolo numero AUC può nascondere pericolose disparità. Gli strumenti diagnostici emergenti basati sull'intelligenza artificiale devono essere valutati con lo stesso rigore di qualsiasi test diagnostico: stratificati per popolazione, convalidati esternamente e conformi agli standard STARD e QUADAS-2.</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">The Checklist</div>
<div class="lesson-item animate delay-1">
<div class="lesson-number" style="background:var(--green);">✓</div>
<div class="lesson-content">
<h4>Was there a valid reference standard?</h4>
<p>Gold standard applied to ALL patients?</p>
</div>
</div>
<div class="lesson-item animate delay-2">
<div class="lesson-number" style="background:var(--green);">✓</div>
<div class="lesson-content">
<h4>Gli interpreti erano accecati?</h4>
<p>Test readers unaware of diagnosis?</p>
</div>
</div>
<div class="lesson-item animate delay-3">
<div class="lesson-number" style="background:var(--green);">✓</div>
<div class="lesson-content">
<h4>Lo spettro era appropriato?</h4>
<p>Pazienti simili alla vostra popolazione?</p>
</div>
</div>
<div class="lesson-item animate delay-4">
<div class="lesson-number" style="background:var(--green);">✓</div>
<div class="lesson-content">
<h4>Era la soglia pre-specificata?</h4>
<p>O scelti per massimizzare i risultati?</p>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">When Results Don't Match Suspicion</div>
<div class="decision-tree animate delay-1">
<h4>The Clinical Override Decision Tree</h4>
<div class="tree-row"><div class="tree-node warning">Test Negative, High Suspicion</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node question">What Is the LR-?</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-label">LR- &lt; 0.1</div>
<div class="tree-node tp">Strong rule-out<small>Accept negative</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">LR- 0.1-0.5</div>
<div class="tree-node action">Repeat test<small>Or different test</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-label">LR- &gt; 0.5</div>
<div class="tree-node warning">Trust judgment<small>Test is weak</small></div>
</div>
</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Sequential Testing Decision Tree</div>
<div class="decision-tree animate delay-1">
<h4>When One Test Isn't Enough</h4>
<div class="tree-row"><div class="tree-node root">Initial Screening Test</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-node tp">Positive</div>
<div class="tree-arrow">↓</div>
<div class="tree-node action">Confirmatory Test<small>High specificity</small></div>
<div class="tree-arrow">↓</div>
<div class="tree-branch" style="gap:0.3rem;">
<div class="tree-branch-item">
<div class="tree-node tp" style="font-size:0.5rem;">Positive<small>Diagnose</small></div>
</div>
<div class="tree-branch-item">
<div class="tree-node fn" style="font-size:0.5rem;">Negative<small>False alarm</small></div>
</div>
</div>
</div>
<div class="tree-branch-item">
<div class="tree-node tn">Negative</div>
<div class="tree-arrow">↓</div>
<div class="tree-node action">Likely negative<small>If high sens screen</small></div>
</div>
</div>
</div>
</div>
</div>
<div class="slide hope">
<div class="content text-center">
<div class="refrain hope animate">
                  "Armed with sensitivity, specificity, likelihood,<br/>
                  armato dello SROC e della misura dell'accordo,<br/>
                  puoi vedere oltre la menzogna del test—<br/>
                  e giudicarne la verità te stesso."
                </div>
</div>
</div>
</div>
 ==================== MODULO 19: ERRORI DI TRASFUSIONE DI SANGUE ==================== 
<div class="module-slides" data-module="19">
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai sentito parlare del paziente<br/>
                  che ha ricevuto il <em>wrong blood</em>,<br/>
                  non perché il test fosse sbagliato,<br/>
                  but because <em>no one performed it</em>?
                </div>
</div>
</div>
<div class="slide blood">
<div class="content text-center">
<div class="title red animate">Il test che non era Fatto</div>
<div class="story-card animate delay-1">
<div class="place">HOSPITALS WORLDWIDE</div>
<div class="narrative">
                    ABO blood typing is nearly 100% accurate when performed.
                    <br/><br/>
                    Yet <strong>transfusion reactions still kill</strong>—non a causa del fallimento del test, ma da <strong>human failure</strong>:
                    <br/><br/>
                    • Wrong blood drawn from wrong patient<br/>
                    • Le etichette scambiate in laboratorio<br/>
                    • Bedside check skipped in emergency<br/>
<br/>
                    In the UK, <strong>1 in 13,000 transfusions</strong> sono state inviate al paziente sbagliato. Il test ha funzionato. Il sistema non è riuscito.
                  </div>
<div class="source">Bolton-Maggs PHB. Transfus Med. 2016;26:303-311</div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Test vs. System Decision Tree</div>
<div class="decision-tree animate delay-1">
<h4>Where Can Things Go Wrong?</h4>
<div class="tree-row"><div class="tree-node root">Diagnostic Process</div></div>
<div class="tree-arrow">↓</div>
<div class="tree-row"><div class="tree-node question">Error Source?</div></div>
<div class="tree-branch">
<div class="tree-branch-item">
<div class="tree-label">Test itself</div>
<div class="tree-node warning">Analytical Error<small>Sens/Spec issue</small></div>
<div class="tree-arrow">↓</div>
<div class="tree-node action">Better test needed</div>
</div>
<div class="tree-branch-item">
<div class="tree-label">Pre-analytical</div>
<div class="tree-node fp">Wrong sample<small>ID error</small></div>
<div class="tree-arrow">↓</div>
<div class="tree-node action">System fix needed</div>
</div>
<div class="tree-branch-item">
<div class="tree-label">Post-analytical</div>
<div class="tree-node fp">Wrong action<small>Reporting error</small></div>
<div class="tree-arrow">↓</div>
<div class="tree-node action">Process fix needed</div>
</div>
</div>
</div>
</div>
</div>
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "The perfect test means nothing<br/>
                  se il sangue è sbagliato disegnato,<br/>
                  viene applicata l'etichetta sbagliata,<br/>
                  è appesa la borsa sbagliata."
                </div>
<div class="gold-line animate delay-2"></div>
<p class="animate delay-3" style="color:rgba(255,255,255,0.6);font-style:italic;font-size:0.8rem;">
                  Gli studi DTA misurano l'accuratezza del test. Non misurano la precisione del sistema.
                </p>
</div>
</div>
</div>
 ==================== MODULO 20: QUIZ E RIFERIMENTI ==================== 
<div class="module-slides" data-module="20">
<div class="slide dark active">
<div class="content text-center">
<div class="title gold animate">References</div>
<div class="references animate delay-1">
<h4>Key Sources</h4>
<ol>
<li>Carreyrou J. Bad Blood. Knopf, 2018. [Theranos]</li>
<li>CDC. MMWR. 1987;36(49):833-840. [HIV blood supply]</li>
<li>Herbst AL et al. N Engl J Med. 1971;284:878-881. [DES]</li>
<li>Moyer VA. Ann Intern Med. 2012;157:120-134. [PSA]</li>
<li>Pope JH et al. N Engl J Med. 2000;342:1163-1170. [Troponin]</li>
<li>Steingart KR et al. Cochrane 2014;1:CD009593. [GeneXpert]</li>
<li>Dinnes J et al. Cochrane 2022;7:CD013705. [COVID RAT]</li>
<li>UK Panel. Lancet. 2012;380:1778-1786. [Mammography]</li>
<li>Jack CR et al. Lancet Neurol. 2018;17:760-773. [Amyloid]</li>
<li>WHO. Malaria RDT Performance. 2022.</li>
<li>Reitsma JB et al. J Clin Epidemiol. 2005;58:982-990. [Bivariate]</li>
<li>Whiting PF et al. Ann Intern Med. 2011;155:529-536. [QUADAS-2]</li>
<li>Bolton-Maggs PHB. Transfus Med. 2016;26:303-311.</li>
</ol>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="quiz-container animate">
<div class="quiz-question">Un test è sensibile al 99% e specifico al 99%. La prevalenza della malattia è 1/1000. Un paziente risulta positivo. Qual è la probabilità che abbiano la malattia?</div>
<div class="quiz-options">
<div class="quiz-option" data-correct="false" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">99%</div>
<div class="quiz-option" data-correct="false" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">90%</div>
<div class="quiz-option" data-correct="true" onclick="checkAnswer(this, true)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">About 9%</div>
<div class="quiz-option" data-correct="false" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">50%</div>
</div>
<div class="quiz-feedback"></div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="quiz-container animate">
<div class="quiz-question">What does "SnNout" mean?</div>
<div class="quiz-options">
<div class="quiz-option" data-correct="true" onclick="checkAnswer(this, true)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">A highly Sensitive test, when Negative, rules OUT disease</div>
<div class="quiz-option" data-correct="false" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">A highly Specific test, when Negative, rules OUT disease</div>
<div class="quiz-option" data-correct="false" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Sensitivity should be used for screening</div>
<div class="quiz-option" data-correct="false" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Specificity should be above 90%</div>
</div>
<div class="quiz-feedback"></div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="quiz-container animate">
<div class="quiz-question">Perché il sangue è stato contaminato dall'HIV nonostante i test?</div>
<div class="quiz-options">
<div class="quiz-option" data-correct="false" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">The tests had low specificity</div>
<div class="quiz-option" data-correct="true" onclick="checkAnswer(this, true)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Tests had a window period with zero sensitivity in early infection</div>
<div class="quiz-option" data-correct="false" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">I test non sono stati eseguiti correttamente</div>
<div class="quiz-option" data-correct="false" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">I test erano troppo costosi</div>
</div>
<div class="quiz-feedback"></div>
</div>
</div>
</div>
<div class="slide dark">
<div class="content text-center">
<div class="quiz-container animate">
<div class="quiz-question">Quale dominio QUADAS-2 valuta se il test è stato interpretato senza conoscere il diagnosi?</div>
<div class="quiz-options">
<div class="quiz-option" data-correct="false" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Patient Selection</div>
<div class="quiz-option" data-correct="true" onclick="checkAnswer(this, true)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Index Test</div>
<div class="quiz-option" data-correct="false" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Reference Standard</div>
<div class="quiz-option" data-correct="false" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Flusso e tempistiche</div>
</div>
<div class="quiz-feedback"></div>
</div>
</div>
</div>
<div class="slide hope">
<div class="content text-center">
<div class="big-number green animate" style="font-size:3.5rem;">✔</div>
<div class="title green animate delay-1">Course Complete</div>
<div class="gold-line animate delay-2"></div>
<div class="refrain hope animate delay-3">
                  "Ora conosci i quattro risultati,<br/>
                  le due virtù di un test,<br/>
                  L'errore della base tasso,<br/>
                  l'arte di mettere in comune le prove,<br/>
                  e i pregiudizi che nascondono la verità.<br/>
<br/>
                  Quando la prossima prova ti mentirà:<br/>
<em>lo saprai.</em>"
                </div>
</div>
</div>
</div>
<div class="slide-nav">
<button class="nav-btn" onclick="prevSlide()">←</button>
<div class="nav-center">
<div class="slide-counter" id="slideCounter">1 / 4</div>
<div class="progress" id="progressDots"></div>
</div>
<button class="nav-btn" onclick="nextSlide()">→</button>
</div>
</div>
</div>
</main>
</div>
<script>
    function toggleSidebar() {
      const sidebar = document.querySelector('.sidebar');
      const overlay = document.querySelector('.sidebar-overlay');
      const toggle = document.querySelector('.mobile-menu-toggle');
      if (!sidebar) return;
      const isOpen = sidebar.classList.toggle('open');
      if (overlay) overlay.classList.toggle('show', isOpen);
      if (toggle) toggle.setAttribute('aria-expanded', String(isOpen));
    }

    const modules = [
      { id: 1, title: "The Fraud", subtitle: "Theranos", slides: 4 },
      { id: 2, title: "Four Outcomes", subtitle: "TP/FP/FN/TN", slides: 5 },
      { id: 3, title: "HIV Window", subtitle: "Blood supply crisis", slides: 5 },
      { id: 4, title: "DES Tragedy", subtitle: "Cancer in daughters", slides: 5 },
      { id: 5, title: "Sens & Spec", subtitle: "Le due virtù", slides: 6 },
      { id: 6, title: "Base Rate Fallacy", subtitle: "L'errore più mortale", slides: 6 },
      { id: 7, title: "TB GeneXpert", subtitle: "Missed resistance", slides: 5 },
      { id: 8, title: "PSA Tragedy", subtitle: "Overdiagnosis", slides: 5 },
      { id: 9, title: "Troponin", subtitle: "Timing matters", slides: 5 },
      { id: 10, title: "Likelihood Ratios", subtitle: "Cosa significano i risultati", slides: 6 },
      { id: 11, title: "Malaria RDTs", subtitle: "When tests miss", slides: 5 },
      { id: 12, title: "COVID Tests", subtitle: "False security", slides: 5 },
      { id: 13, title: "Mammography", subtitle: "Finding too much", slides: 6 },
      { id: 14, title: "Amyloid Testing", subtitle: "Surrogate markers", slides: 4 },
      { id: 15, title: "QUADAS-2", subtitle: "Quality assessment", slides: 6 },
      { id: 16, title: "Meta-Analysis", subtitle: "SROC curves", slides: 6 },
      { id: 17, title: "Heterogeneity", subtitle: "Quando gli studi non sono d'accordo", slides: 5 },
      { id: 18, title: "The Toolkit", subtitle: "Clinical decisions", slides: 6 },
      { id: 19, title: "System Errors", subtitle: "Oltre il test", slides: 4 },
      { id: 20, title: "Quiz & Sources", subtitle: "Test yourself", slides: 6 }
    ];

    let currentModule = 1;
    let currentSlide = 1;
    const completedModules = new Set();

    function init() {
      renderModuleList();
      updateSlideNav();
      document.addEventListener('keydown', (e) => {
        const tag = document.activeElement?.tagName;
        if (tag === 'INPUT' || tag === 'TEXTAREA' || tag === 'SELECT' || tag === 'BUTTON') return;
        const role = document.activeElement?.getAttribute?.('role');
        if (role === 'button' || role === 'radio' || role === 'option') {
          if (e.key === ' ' || e.key === 'Enter') { e.preventDefault(); document.activeElement.click(); }
          return;
        }
        if (e.key === 'ArrowRight' || e.key === ' ') { e.preventDefault(); nextSlide(); }
        else if (e.key === 'ArrowLeft') { e.preventDefault(); prevSlide(); }
      });
    }

    function renderModuleList() {
      const list = document.getElementById('moduleList');
      list.innerHTML = modules.map(m => `
        <div class="module-item ${m.id === currentModule ? 'active' : ''} ${completedModules.has(m.id) ? 'completed' : ''}" onclick="goToModule(${m.id})" tabindex="0" role="button" aria-label="Module ${m.id}: ${m.title}" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();goToModule(${m.id});}">
          <div class="module-number">${completedModules.has(m.id) ? '✓' : m.id}</div>
          <div class="module-info">
            <div class="module-title">${m.title}</div>
            <div class="module-subtitle">${m.subtitle}</div>
          </div>
        </div>
      `).join('');
    }

    function goToModule(moduleId) {
      if (moduleId > currentModule) completedModules.add(currentModule);
      currentModule = moduleId;
      currentSlide = 1;
      document.querySelectorAll('.module-slides').forEach(el => el.classList.remove('active'));
      document.querySelector(`.module-slides[data-module="${moduleId}"]`).classList.add('active');
      updateSlideVisibility();
      updateSlideNav();
      renderModuleList();
      document.getElementById('currentModule').textContent = modules[moduleId - 1].title;
    }

    function updateSlideVisibility() {
      const moduleSlides = document.querySelector(`.module-slides[data-module="${currentModule}"]`);
      const slides = moduleSlides.querySelectorAll('.slide');
      slides.forEach((slide, index) => slide.classList.toggle('active', index + 1 === currentSlide));
    }

    function updateSlideNav() {
      const module = modules[currentModule - 1];
      document.getElementById('slideCounter').textContent = `${currentSlide} / ${module.slides}`;
      document.getElementById('progressDots').innerHTML = Array.from({ length: module.slides }, (_, i) =>
        `<div class="progress-dot ${i + 1 === currentSlide ? 'active' : ''}" onclick="goToSlide(${i + 1})"></div>`
      ).join('');
    }

    function goToSlide(slideNum) { currentSlide = slideNum; updateSlideVisibility(); updateSlideNav(); }

    function nextSlide() {
      const module = modules[currentModule - 1];
      if (currentSlide < module.slides) { currentSlide++; updateSlideVisibility(); updateSlideNav(); }
      else if (currentModule < modules.length) { goToModule(currentModule + 1); }
    }

    function prevSlide() {
      if (currentSlide > 1) { currentSlide--; updateSlideVisibility(); updateSlideNav(); }
      else if (currentModule > 1) {
        const prevModuleSlides = modules[currentModule - 2].slides;
        currentModule--;
        currentSlide = prevModuleSlides;
        document.querySelectorAll('.module-slides').forEach(el => el.classList.remove('active'));
        document.querySelector(`.module-slides[data-module="${currentModule}"]`).classList.add('active');
        updateSlideVisibility();
        updateSlideNav();
        renderModuleList();
        document.getElementById('currentModule').textContent = modules[currentModule - 1].title;
      }
    }

    function checkAnswer(element, isCorrect) {
      const container = element.closest('.quiz-container');
      const options = container.querySelectorAll('.quiz-option');
      const feedback = container.querySelector('.quiz-feedback');
      options.forEach(opt => {
        opt.style.pointerEvents = 'none';
        if (opt === element) opt.classList.add(isCorrect ? 'correct' : 'incorrect');
        if (!isCorrect && opt.dataset.correct === 'true') opt.classList.add('correct');
      });
      feedback.classList.add('show', isCorrect ? 'correct' : 'incorrect');
      feedback.textContent = isCorrect ? 'Corretto. Hai capito.' : 'Non proprio. Rifletti sulle storie che hai sentito.';
    }

    // Interactive Base Rate Calculator
    function updateCalc() {
      const prev = parseFloat(document.getElementById('prevSlider').value);
      const sens = parseFloat(document.getElementById('sensSlider').value);
      const spec = parseFloat(document.getElementById('specSlider').value);

      document.getElementById('prevValue').textContent = prev.toFixed(1) + '%';
      document.getElementById('sensValue').textContent = sens + '%';
      document.getElementById('specValue').textContent = spec + '%';

      // Calculate PPV
      const prevDecimal = prev / 100;
      const sensDecimal = sens / 100;
      const specDecimal = spec / 100;

      const tp = prevDecimal * sensDecimal;
      const fp = (1 - prevDecimal) * (1 - specDecimal);
      const ppv = (tp + fp === 0) ? 0 : tp / (tp + fp) * 100;

      document.getElementById('ppvResult').textContent = ppv.toFixed(1) + '%';
      document.getElementById('fpRate').textContent = (100 - ppv).toFixed(0) + '% dei positivi sono falsi allarmi';
    }

    init();
  </script>
</body>
</html>
